NP Entry ID,Study ID,DOI,Title,Year,Core NP Material,Surface Modification,Modification Type,Modification Charge,NP Type,NP Sub-Type,Lipid Core Molar Ratio,NP Shape,Size Method,HD Solvent,Size (nm),Size Group,Zeta Potential Solvent,Zeta Potential (mV),Zeta Potential Group,Zeta Potential Charge,PDI,PDI Group,Incubation Protein Source,Incubation Media Additives,Incubation Media,Incubation Protein Concentration (%-v/v),Plasma Concentation Group,NP Solution Concentration,NP Solution Concentration Units,Dispersion medium Volume (µL),Final NP Incubation Mass (mg),Mass Group,Incubation time (min),Incubation time Group,Shaking or AgitationDuring Incubation,Incubation Temp (°C),NP-PC Isolation Method,Extraction Centrifugation Speed (xg),Isolation Temperature (°C),Extraction Centrifugation Time (min),Number of Washing Steps,Exposure type,Species,Protein Composition Units,No Proteins Identified,Protein Entry No,Study ID,APOE,APOB,CO3,CLUS
A001,A01,https://doi.org/10.1021/acsbiomaterials.1c00804,Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells,2021,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,101,100~150,PBS,-15,-50~-10,Negative,0.06,0~0.1,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,4,in vitro,Human,%-RPA,4,A001,A01,5.192980563,1.211149915,1.094400849,0.243855167
A002,A01,https://doi.org/10.1021/acsbiomaterials.1c00804,Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells,2021,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,165,>150,PBS,-12,-50~-10,Negative,0.05,0~0.1,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,4,in vitro,Human,%-RPA,4,A002,A01,2.971380527,1.356342052,1.13760959,0.446502111
A003,A01,https://doi.org/10.1021/acsbiomaterials.1c00804,Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells,2021,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,PBS,100,100~150,PBS,-11,-50~-10,Negative,0.04,0~0.1,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,4,in vitro,Human,%-RPA,4,A003,A01,3.047990607,0.956093829,1.2174314,0.226943934
A004,A01,https://doi.org/10.1021/acsbiomaterials.1c00804,Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells,2021,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,PBS,192,>150,PBS,-7,-10~+10,Neutral,0.04,0~0.1,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,4,in vitro,Human,%-RPA,4,A004,A01,3.324502488,1.339134916,1.182662757,0.502611015
A005,A01,https://doi.org/10.1021/acsbiomaterials.1c00804,Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells,2021,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,PBS,105,100~150,PBS,-15,-50~-10,Negative,0.02,0~0.1,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,4,in vitro,Human,%-RPA,4,A005,A01,3.962498073,0.819610168,1.445927905,0.192965023
A006,A01,https://doi.org/10.1021/acsbiomaterials.1c00804,Correlating Corona Composition and Cell Uptake to Identify Proteins Affecting Nanoparticle Entry into Endothelial Cells,2021,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,PBS,203,>150,PBS,-13,-50~-10,Negative,0.05,0~0.1,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,4,in vitro,Human,%-RPA,4,A006,A01,1.976566483,1.832282496,1.455768918,0.510492518
A012,A02,https://doi.org/10.1016/j.jprot.2015.02.009,Surface chemistry and serum type both determine the nanoparticle–protein corona,2015,Shingosine-Chol-DSPC,No Modification,No Modification,No Modification,Organic,Lipid,3:2:5,Sphere,DLS,DI-H2O,193.4,>150,DI-H2O,39.9,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,170,1,0~5,60,30~60,N,37,Centrifugation,18000,Not Reported,15,3,in vitro,Human,%-RPA,4,A012,A02,1.01974215,1.26841017,4.2946024,0.59839814
A013,A02,https://doi.org/10.1016/j.jprot.2015.02.009,Surface chemistry and serum type both determine the nanoparticle–protein corona,2015,DOTAP-CHOL-DPPC,No Modification,No Modification,No Modification,Organic,Lipid,3:2:5,Sphere,DLS,DI-H2O,209.9,>150,DI-H2O,32.5,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,170,1,0~5,60,30~60,N,37,Centrifugation,18000,Not Reported,15,3,in vitro,Human,%-RPA,4,A013,A02,1.11847484,0.50335655,1.88583652,0.91047445
A014,A02,https://doi.org/10.1016/j.jprot.2015.02.009,Surface chemistry and serum type both determine the nanoparticle–protein corona,2015,DOTAP-CHOL-DSPC,No Modification,No Modification,No Modification,Organic,Lipid,3:2:5,Sphere,DLS,DI-H2O,470.3,>150,DI-H2O,31.1,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,170,1,0~5,60,30~60,N,37,Centrifugation,18000,Not Reported,15,3,in vitro,Human,%-RPA,4,A014,A02,0.89794872,0.61951501,2.52044549,0.57560816
A015,A02,https://doi.org/10.1016/j.jprot.2015.02.009,Surface chemistry and serum type both determine the nanoparticle–protein corona,2015,DOTAP-CHOL-PC,No Modification,No Modification,No Modification,Organic,Lipid,3:2:5,Sphere,DLS,DI-H2O,254.6,>150,DI-H2O,29.7,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,170,1,0~5,60,30~60,N,37,Centrifugation,18000,Not Reported,15,3,in vitro,Human,%-RPA,4,A015,A02,0.75582959,0.54197083,2.30992839,0.6540833
A016,A02,https://doi.org/10.1016/j.jprot.2015.02.009,Surface chemistry and serum type both determine the nanoparticle–protein corona,2015,CHOL-PC,No Modification,No Modification,No Modification,Organic,Lipid,0:2:8,Sphere,DLS,DI-H2O,191,>150,DI-H2O,-7.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,170,1,0~5,60,30~60,N,37,Centrifugation,18000,Not Reported,15,3,in vitro,Human,%-RPA,4,A016,A02,1.42031436,0.97813097,3.45976524,0.57094523
A024,A05,https://doi.org/10.1016/j.biomaterials.2015.10.019,Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake,2016,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,PBS,94.1,50~100,PBS,-29.83,-50~-10,Negative,0.086,0~0.1,Human Plasma,None,PBS,55,50~100,500,ug,Not Reported,0.5,0~5,60,30~60,Y,37,Centrifugation,Not Reported,4,Not Reported,2,in vitro,Human,%-RPA,2,A024,A05,33.18,0,0.83,0
A025,A05,https://doi.org/10.1016/j.biomaterials.2015.10.019,Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake,2016,Silica,COOH-HSA,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,PBS,343.9,>150,PBS,-17.03,-50~-10,Negative,0.338,>0.2,Human Plasma,None,PBS,55,50~100,500,ug,Not Reported,0.5,0~5,60,30~60,Y,37,Centrifugation,Not Reported,4,Not Reported,2,in vitro,Human,%-RPA,2,A025,A05,45.31,0,0.78,0
A026,A05,https://doi.org/10.1016/j.biomaterials.2015.10.019,Impact of protein pre-coating on the protein corona composition and nanoparticle cellular uptake,2016,Silica,COOH-GG,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,PBS,749.2,>150,PBS,-12.79,-50~-10,Negative,0.336,>0.2,Human Plasma,None,PBS,55,50~100,500,ug,Not Reported,0.5,0~5,60,30~60,Y,37,Centrifugation,Not Reported,4,Not Reported,2,in vitro,Human,%-RPA,3,A026,A05,3.46,6.97,2.72,0
A041,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (20) sorbitan monolaurate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,87.5,50~100,HEPES,-22.8089,-50~-10,Negative,0.1208,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A041,A08,9.843398257,0,0,0
A042,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (20) sorbitan monolaurate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,109.26,100~150,HEPES,-20.337,-50~-10,Negative,0.08,0~0.1,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A042,A08,9.700296157,0,0,0
A043,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,44.82,<50,HEPES,-20.224,-50~-10,Negative,0.13011,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A043,A08,11.79119223,0,0,0
A044,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,88.95,50~100,HEPES,-20.337,-50~-10,Negative,0.15148,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A044,A08,11.82659874,0,0,0
A045,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,123.277,100~150,HEPES,-23.82,-50~-10,Negative,0.1013,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A045,A08,10.52516376,0,0,0
A046,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,149.88,100~150,HEPES,-25.95505,-50~-10,Negative,0.1598,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A046,A08,10.71951594,0,0,0
A047,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate:Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,90.35,50~100,HEPES,-26.5168,-50~-10,Negative,0.19981,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A047,A08,19.99564383,0,0,0
A048,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate:Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,126.77,100~150,HEPES,-26.3774,-50~-10,Negative,0.14126,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A048,A08,15.12151456,0,0,0
A049,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (20) sorbitan monolaurate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,87.5,50~100,HEPES,-22.8089,-50~-10,Negative,0.1208,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A049,A08,9.843398257,0,0,0
A050,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (20) sorbitan monolaurate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,109.26,100~150,HEPES,-20.337,-50~-10,Negative,0.08,0~0.1,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A050,A08,9.700296157,0,0,0
A051,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,44.82,<50,HEPES,-20.224,-50~-10,Negative,0.13011,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A051,A08,11.79119223,0,0,0
A052,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,88.95,50~100,HEPES,-20.337,-50~-10,Negative,0.15148,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A052,A08,11.82659874,0,0,0
A053,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,123.277,100~150,HEPES,-23.82,-50~-10,Negative,0.1013,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A053,A08,10.52516376,0,0,0
A054,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,149.88,100~150,HEPES,-25.95505,-50~-10,Negative,0.1598,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A054,A08,10.71951594,0,0,0
A055,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate:Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,90.35,50~100,HEPES,-26.5168,-50~-10,Negative,0.19981,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A055,A08,19.99564383,0,0,0
A056,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate:Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,126.77,100~150,HEPES,-26.3774,-50~-10,Negative,0.14126,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A056,A08,15.12151456,0,0,0
A057,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (20) sorbitan monolaurate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,87.5,50~100,HEPES,-22.8089,-50~-10,Negative,0.1208,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A057,A08,9.843398257,0,0,0
A058,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (20) sorbitan monolaurate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,109.26,100~150,HEPES,-20.337,-50~-10,Negative,0.08,0~0.1,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A058,A08,9.700296157,0,0,0
A059,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,44.82,<50,HEPES,-20.224,-50~-10,Negative,0.13011,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A059,A08,11.79119223,0,0,0
A060,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,88.95,50~100,HEPES,-20.337,-50~-10,Negative,0.15148,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A060,A08,11.82659874,0,0,0
A061,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,123.277,100~150,HEPES,-23.82,-50~-10,Negative,0.1013,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A061,A08,10.52516376,0,0,0
A062,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,149.88,100~150,HEPES,-25.95505,-50~-10,Negative,0.1598,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A062,A08,10.71951594,0,0,0
A063,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate:Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,90.35,50~100,HEPES,-26.5168,-50~-10,Negative,0.19981,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A063,A08,19.99564383,0,0,0
A064,A08,https://doi.org/10.1039/d0nr07229j,Nano-bio interface between human plasma and niosomes with different formulations indicates protein corona patterns for nanoparticle cell targeting and uptake,2021,Polyoxyethylene (21) sorbitan monooleate:Polyoxyethylene (80) sorbitan monooleate,No Modification,No Modification,No Modification,Organic,Niosome,N/A,Sphere,DLS,HEPES,126.77,100~150,HEPES,-26.3774,-50~-10,Negative,0.14126,0.1~0.2,Human Plasma,None,N/A,100,50~100,1.67,mg/mL,450,0.7515,0~5,60,30~60,N,37,Centrifugation,15000,Not Reported,10,2,in vitro,Human,%-RPA,1,A064,A08,15.12151456,0,0,0
A065,A09,https://doi.org/10.1021/acsnano.9b03824,Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles,2019,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,DI-H2O,47,<50,DI-H2O,-40,-50~-10,Negative,0.07,0~0.1,Human Plasma,None,MEM + PBS,10,<50,300,µg/mL,Not Reported,0.3,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,1,in vitro,Human,%-RPA,4,A065,A09,3.948739468,2.556976444,0.886913337,0.671695847
A066,A09,https://doi.org/10.1021/acsnano.9b03824,Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles,2019,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,DI-H2O,47,<50,DI-H2O,-40,-50~-10,Negative,0.07,0~0.1,Human Plasma,None,MEM + PBS,50,50~100,300,µg/mL,Not Reported,0.3,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,1,in vitro,Human,%-RPA,4,A066,A09,3.206632246,2.240420342,0.774341709,0.650704015
A067,A09,https://doi.org/10.1021/acsnano.9b03824,Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles,2019,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DCS,PBS,35.8,<50,DI-H2O,-40,-50~-10,Negative,0.07,0~0.1,Human Plasma,None,MEM + PBS,10,<50,300,µg/mL,Not Reported,0.3,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,1,in vitro,Human,%-RPA,4,A067,A09,3.948739468,2.556976444,0.886913337,0.671695847
A068,A09,https://doi.org/10.1021/acsnano.9b03824,Corona Composition Can Affect the Mechanisms Cells Use to Internalize Nanoparticles,2019,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DCS,PBS,35.8,<50,DI-H2O,-40,-50~-10,Negative,0.07,0~0.1,Human Plasma,None,MEM + PBS,50,50~100,300,µg/mL,Not Reported,0.3,0~5,60,30~60,Y,37,Centrifugation,16000,15,60,1,in vitro,Human,%-RPA,4,A068,A09,3.206632246,2.240420342,0.774341709,0.650704015
A069,A10,https://doi.org/10.1186/s12951-020-00676-5,Plasma proteins facilitates placental transfer of polystyrene particles,2020,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,NTA,PBS,89,50~100,PBS,-27.63,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,DMEM,8.6,<50,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,>60,N,37,Centrifugation,5000,4,10,3,in vitro,Human,Log2 Peptide Intensity,4,A069,A10,7.56321,6.549753,6.5827,8.611598
A070,A10,https://doi.org/10.1186/s12951-020-00676-5,Plasma proteins facilitates placental transfer of polystyrene particles,2020,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,NTA,PBS,89,50~100,PBS,-27.63,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,DMEM,8.6,<50,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,>60,N,37,Centrifugation,5000,4,10,3,in vitro,Human,Log2 Peptide Intensity,4,A070,A10,2.95271,3.402455,4.158905,1.9108
A071,A10,https://doi.org/10.1186/s12951-020-00676-5,Plasma proteins facilitates placental transfer of polystyrene particles,2020,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,NTA,PBS,89,50~100,PBS,-27.63,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,DMEM,8.6,<50,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,>60,N,37,Centrifugation,5000,4,10,3,in vitro,Human,Log2 Peptide Intensity,4,A071,A10,0.284797,0.131989,3.344378,1.169156
A072,A11,https://doi.org/10.1016/j.colsurfb.2022.112981,Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles,2023,Iron Oxide,PEG,Polymeric,Neutral,Inorganic,Metal Oxide,N/A,Sphere,DLS,D-H2O,166,>150,DI-H2O,-12.8,-50~-10,Negative,0.06,0~0.1,Human Plasma,None,N/A,100,50~100,36,µg/mL,360,0.0144,0~5,60,30~60,Y,37,Magnetic Pulldown,N/A,4,720,1,in vitro,Human,%-RPA,3,A072,A11,0.883879539,na,2.186109057,0.875601821
A073,A11,https://doi.org/10.1016/j.colsurfb.2022.112981,Peptide ligands on the PEGylated nanoparticle surface and human serum composition are key factors for the interaction between immune cells and nanoparticles,2023,Iron Oxide,pHILP,Peptide,Neutral,Inorganic,Metal Oxide,N/A,Sphere,DLS,D-H2O,169,>150,DI-H2O,-17.3,-50~-10,Negative,0.04,0~0.1,Human Plasma,None,N/A,100,50~100,36,µg/mL,360,0.0144,0~5,60,30~60,Y,37,Magnetic Pulldown,N/A,4,720,1,in vitro,Human,%-RPA,3,A073,A11,0.633202693,na,4.272523376,2.359409371
A084,A13,https://doi.org/10.1021/acs.langmuir.5b02158,Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells,2015,DOPG,No Modification,No Modification,No Modification,Organic,Lipid,N/A,Sphere,DLS,DI-H2O,136,100~150,DI-H2O,-25.6,-50~-10,Negative,0.04,0~0.1,Human Plasma,None,N/A,100,50~100,1,mg/mL,400,0.2,0~5,60,30~60,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,4,A084,A13,1.09439496,0.69511102,1.38997813,1.68259125
A085,A13,https://doi.org/10.1021/acs.langmuir.5b02158,Stealth Effect of Biomolecular Corona on Nanoparticle Uptake by Immune Cells,2015,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,DI-H2O,390,>150,DI-H2O,-22.4,-50~-10,Negative,0.89,>0.2,Human Plasma,None,N/A,100,50~100,1,mg/mL,400,0.2,0~5,60,30~60,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,4,A085,A13,0.84811503,0.15805903,0.43837812,0.67563221
A086,A14,https://doi.org/10.1021/acsami.7b16096,Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona,2018,Polystyrene,PEG,Polymeric,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,PBS,80.77,50~100,PBS,2.11,-10~+10,Neutral,0.15,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,mg/mL,1000,4,0~5,60,30~60,Y,37,SEC,N/A,N/A,N/A,1,in vitro,Human,%-RPA,2,A086,A14,0,0.0036,na,0.0155
A087,A14,https://doi.org/10.1021/acsami.7b16096,Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona,2018,Polystyrene,CHAIYPRH (LT7) peptide,Peptide,Positive,Organic,Polystyrene,N/A,Sphere,DLS,PBS,89.5,50~100,PBS,16.2,+10~+50,Positive,0.12,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,mg/mL,1000,4,0~5,60,30~60,Y,37,SEC,N/A,N/A,N/A,1,in vitro,Human,%-RPA,2,A087,A14,0,0.0202,na,0.0172
A088,A14,https://doi.org/10.1021/acsami.7b16096,Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona,2018,Polystyrene,"hrpyiahc, all D-form amino acids (DT7)",Amino Acid,Positive,Organic,Polystyrene,N/A,Sphere,DLS,PBS,83.61,50~100,PBS,17.1,+10~+50,Positive,0.15,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,mg/mL,1000,4,0~5,60,30~60,Y,37,SEC,N/A,N/A,N/A,1,in vitro,Human,%-RPA,2,A088,A14,0,0.0055,na,0.0078
A089,A14,https://doi.org/10.1021/acsami.7b16096,Ligand Size and Conformation Affect the Behavior of Nanoparticles Coated with in Vitro and in Vivo Protein Corona,2018,Polystyrene,Transferrin,Peptide,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,92.47,50~100,PBS,1.25,-10~+10,Neutral,0.15,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,mg/mL,1000,4,0~5,60,30~60,Y,37,SEC,N/A,N/A,N/A,1,in vitro,Human,%-RPA,2,A089,A14,0,0.0163,na,0.0155
A116,A17,https://doi.org/10.1038/nnano.2013.181,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.4,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A116,A17,3054,0,72877,10254
A117,A17,https://doi.org/10.1038/nnano.2013.182,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.4,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A117,A17,8244,0,55999,9555
A118,A17,https://doi.org/10.1038/nnano.2013.183,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.4,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A118,A17,5510,0,47212,10049
A119,A17,https://doi.org/10.1038/nnano.2013.184,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.4,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A119,A17,5910,0,38130,8843
A120,A17,https://doi.org/10.1038/nnano.2013.185,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.4,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A120,A17,4936,0,65465,9307
A121,A17,https://doi.org/10.1038/nnano.2013.186,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.4,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A121,A17,3422,0,57951,10857
A122,A17,https://doi.org/10.1038/nnano.2013.187,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.4,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A122,A17,1568,0,24746,18931
A123,A17,https://doi.org/10.1038/nnano.2013.188,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,112,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A123,A17,2139,0,111057,9561
A124,A17,https://doi.org/10.1038/nnano.2013.189,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,112,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A124,A17,4207,0,66925,4220
A125,A17,https://doi.org/10.1038/nnano.2013.190,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,112,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A125,A17,6443,0,89790,4531
A126,A17,https://doi.org/10.1038/nnano.2013.191,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,112,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A126,A17,9580,0,80732,5194
A127,A17,https://doi.org/10.1038/nnano.2013.192,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,112,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A127,A17,11380,0,56889,5559
A128,A17,https://doi.org/10.1038/nnano.2013.193,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,112,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A128,A17,10993,0,63789,6276
A129,A17,https://doi.org/10.1038/nnano.2013.194,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,112,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A129,A17,11533,0,61045,6450
A130,A17,https://doi.org/10.1038/nnano.2013.195,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,115,100~150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A130,A17,4661,0,24535,10811
A131,A17,https://doi.org/10.1038/nnano.2013.196,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,115,100~150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A131,A17,6980,0,18522,23417
A132,A17,https://doi.org/10.1038/nnano.2013.197,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,115,100~150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A132,A17,7386,0,32796,41276
A133,A17,https://doi.org/10.1038/nnano.2013.198,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,115,100~150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A133,A17,7320,0,97337,44284
A134,A17,https://doi.org/10.1038/nnano.2013.199,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,115,100~150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A134,A17,9459,0,59611,76096
A135,A17,https://doi.org/10.1038/nnano.2013.200,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,115,100~150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A135,A17,5864,0,62011,45406
A136,A17,https://doi.org/10.1038/nnano.2013.201,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,TEM,N/A,115,100~150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A136,A17,6389,0,53920,40371
A137,A17,https://doi.org/10.1038/nnano.2013.181,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,48,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A137,A17,3054,0,72877,10254
A138,A17,https://doi.org/10.1038/nnano.2013.182,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,48,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A138,A17,8244,0,55999,9555
A139,A17,https://doi.org/10.1038/nnano.2013.183,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,48,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A139,A17,5510,0,47212,10049
A140,A17,https://doi.org/10.1038/nnano.2013.184,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,48,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A140,A17,5910,0,38130,8843
A141,A17,https://doi.org/10.1038/nnano.2013.185,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,48,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A141,A17,4936,0,65465,9307
A142,A17,https://doi.org/10.1038/nnano.2013.186,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,48,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A142,A17,3422,0,57951,10857
A143,A17,https://doi.org/10.1038/nnano.2013.187,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,48,<50,Human Plasma,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A143,A17,1568,0,24746,18931
A144,A17,https://doi.org/10.1038/nnano.2013.188,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,126,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A144,A17,2139,0,111057,9561
A145,A17,https://doi.org/10.1038/nnano.2013.189,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,126,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A145,A17,4207,0,66925,4220
A146,A17,https://doi.org/10.1038/nnano.2013.190,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,126,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A146,A17,6443,0,89790,4531
A147,A17,https://doi.org/10.1038/nnano.2013.191,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,126,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A147,A17,9580,0,80732,5194
A148,A17,https://doi.org/10.1038/nnano.2013.192,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,126,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A148,A17,11380,0,56889,5559
A149,A17,https://doi.org/10.1038/nnano.2013.193,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,126,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A149,A17,10993,0,63789,6276
A150,A17,https://doi.org/10.1038/nnano.2013.194,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,126,100~150,Human Plasma,-55,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A150,A17,11533,0,61045,6450
A151,A17,https://doi.org/10.1038/nnano.2013.195,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,156,>150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A151,A17,4661,0,24535,10811
A152,A17,https://doi.org/10.1038/nnano.2013.196,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,156,>150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A152,A17,6980,0,18522,23417
A153,A17,https://doi.org/10.1038/nnano.2013.197,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,156,>150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A153,A17,7386,0,32796,41276
A154,A17,https://doi.org/10.1038/nnano.2013.198,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,156,>150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A154,A17,7320,0,97337,44284
A155,A17,https://doi.org/10.1038/nnano.2013.199,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,156,>150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A155,A17,9459,0,59611,76096
A156,A17,https://doi.org/10.1038/nnano.2013.200,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,156,>150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A156,A17,5864,0,62011,45406
A157,A17,https://doi.org/10.1038/nnano.2013.201,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,Human Plasma,156,>150,Human Plasma,51,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,600,ug,Not Reported,0.6,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,3,A157,A17,6389,0,53920,40371
A158,A17,https://doi.org/10.1038/nnano.2013.201,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A158,A17,6270,186876,48992,5009
A159,A17,https://doi.org/10.1038/nnano.2013.202,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A159,A17,6279,175657,48238,5834
A160,A17,https://doi.org/10.1038/nnano.2013.203,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A160,A17,5567,167790,49238,3177
A161,A17,https://doi.org/10.1038/nnano.2013.204,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A161,A17,5889,164478,46473,4318
A162,A17,https://doi.org/10.1038/nnano.2013.205,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A162,A17,5549,158498,48532,3616
A163,A17,https://doi.org/10.1038/nnano.2013.206,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A163,A17,5958,169575,54981,3160
A164,A17,https://doi.org/10.1038/nnano.2013.207,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A164,A17,6026,176401,53727,3066
A165,A17,https://doi.org/10.1038/nnano.2013.208,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A165,A17,6458,182267,52033,4671
A166,A17,https://doi.org/10.1038/nnano.2013.209,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,30.2,<50,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A166,A17,6475,190608,50193,4455
A167,A17,https://doi.org/10.1038/nnano.2013.210,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A167,A17,5167,120090,55819,3162
A168,A17,https://doi.org/10.1038/nnano.2013.211,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A168,A17,4774,103680,57141,3062
A169,A17,https://doi.org/10.1038/nnano.2013.212,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A169,A17,5357,147268,55701,2013
A170,A17,https://doi.org/10.1038/nnano.2013.213,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A170,A17,5669,161709,49352,2658
A171,A17,https://doi.org/10.1038/nnano.2013.214,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A171,A17,5615,153620,46910,2631
A172,A17,https://doi.org/10.1038/nnano.2013.215,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A172,A17,5483,150166,54406,2345
A173,A17,https://doi.org/10.1038/nnano.2013.216,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A173,A17,5553,146440,50479,3828
A174,A17,https://doi.org/10.1038/nnano.2013.217,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A174,A17,5863,158221,47152,3955
A175,A17,https://doi.org/10.1038/nnano.2013.218,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,27.2,<50,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A175,A17,5868,178347,42958,3880
A176,A17,https://doi.org/10.1038/nnano.2013.219,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A176,A17,6134,87271,64142,5676
A177,A17,https://doi.org/10.1038/nnano.2013.220,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A177,A17,8159,92179,63791,6634
A178,A17,https://doi.org/10.1038/nnano.2013.221,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A178,A17,9919,110443,52030,7428
A179,A17,https://doi.org/10.1038/nnano.2013.222,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A179,A17,9615,153378,48897,5728
A180,A17,https://doi.org/10.1038/nnano.2013.223,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A180,A17,9948,148351,44685,6924
A181,A17,https://doi.org/10.1038/nnano.2013.224,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A181,A17,10001,142436,45961,6355
A182,A17,https://doi.org/10.1038/nnano.2013.225,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A182,A17,10712,128625,38155,7193
A183,A17,https://doi.org/10.1038/nnano.2013.226,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A183,A17,10546,159330,35565,7087
A184,A17,https://doi.org/10.1038/nnano.2013.227,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,31.6,<50,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A184,A17,8988,160950,31572,7797
A185,A17,https://doi.org/10.1038/nnano.2013.228,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A185,A17,8610,58115,54830,5691
A186,A17,https://doi.org/10.1038/nnano.2013.229,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A186,A17,8334,54295,53790,4930
A187,A17,https://doi.org/10.1038/nnano.2013.230,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A187,A17,9307,60682,49130,5333
A188,A17,https://doi.org/10.1038/nnano.2013.231,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A188,A17,11785,56483,61347,5465
A189,A17,https://doi.org/10.1038/nnano.2013.232,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A189,A17,11729,75230,55294,4844
A190,A17,https://doi.org/10.1038/nnano.2013.233,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A190,A17,11336,65222,27705,4949
A191,A17,https://doi.org/10.1038/nnano.2013.234,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A191,A17,11669,54682,34586,10688
A192,A17,https://doi.org/10.1038/nnano.2013.235,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A192,A17,9808,139619,34251,7503
A193,A17,https://doi.org/10.1038/nnano.2013.236,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,144.8,100~150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A193,A17,9021,128116,21889,7400
A194,A17,https://doi.org/10.1038/nnano.2013.237,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A194,A17,6971,79646,61145,5285
A195,A17,https://doi.org/10.1038/nnano.2013.238,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A195,A17,5922,72147,61824,3825
A196,A17,https://doi.org/10.1038/nnano.2013.239,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A196,A17,7274,72166,49807,6213
A197,A17,https://doi.org/10.1038/nnano.2013.240,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A197,A17,10030,84369,44944,6585
A198,A17,https://doi.org/10.1038/nnano.2013.241,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A198,A17,10543,67900,48168,7368
A199,A17,https://doi.org/10.1038/nnano.2013.242,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A199,A17,10897,83938,43309,7325
A200,A17,https://doi.org/10.1038/nnano.2013.243,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A200,A17,11634,70419,36083,8194
A201,A17,https://doi.org/10.1038/nnano.2013.244,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A201,A17,10675,83157,35829,8990
A202,A17,https://doi.org/10.1038/nnano.2013.245,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,129,100~150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A202,A17,11417,88186,33961,8532
A203,A17,https://doi.org/10.1038/nnano.2013.246,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A203,A17,7423,82636,49914,5337
A204,A17,https://doi.org/10.1038/nnano.2013.247,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A204,A17,7886,64023,66953,5307
A205,A17,https://doi.org/10.1038/nnano.2013.248,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A205,A17,7887,63602,65887,4144
A206,A17,https://doi.org/10.1038/nnano.2013.249,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A206,A17,9390,75155,42679,5075
A207,A17,https://doi.org/10.1038/nnano.2013.250,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A207,A17,9670,84544,34976,4017
A208,A17,https://doi.org/10.1038/nnano.2013.251,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A208,A17,13111,98068,31606,5686
A209,A17,https://doi.org/10.1038/nnano.2013.252,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A209,A17,13443,101294,30812,8107
A210,A17,https://doi.org/10.1038/nnano.2013.253,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A210,A17,12330,99463,31149,7594
A211,A17,https://doi.org/10.1038/nnano.2013.254,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,141,100~150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A211,A17,13746,96776,21822,8779
A212,A17,https://doi.org/10.1038/nnano.2013.201,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A212,A17,6270,186876,48992,5009
A213,A17,https://doi.org/10.1038/nnano.2013.202,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A213,A17,6279,175657,48238,5834
A214,A17,https://doi.org/10.1038/nnano.2013.203,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A214,A17,5567,167790,49238,3177
A215,A17,https://doi.org/10.1038/nnano.2013.204,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A215,A17,5889,164478,46473,4318
A216,A17,https://doi.org/10.1038/nnano.2013.205,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A216,A17,5549,158498,48532,3616
A217,A17,https://doi.org/10.1038/nnano.2013.206,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A217,A17,5958,169575,54981,3160
A218,A17,https://doi.org/10.1038/nnano.2013.207,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A218,A17,6026,176401,53727,3066
A219,A17,https://doi.org/10.1038/nnano.2013.208,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A219,A17,6458,182267,52033,4671
A220,A17,https://doi.org/10.1038/nnano.2013.209,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,72,50~100,Human Plasma,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A220,A17,6475,190608,50193,4455
A221,A17,https://doi.org/10.1038/nnano.2013.210,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A221,A17,5167,120090,55819,3162
A222,A17,https://doi.org/10.1038/nnano.2013.211,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A222,A17,4774,103680,57141,3062
A223,A17,https://doi.org/10.1038/nnano.2013.212,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A223,A17,5357,147268,55701,2013
A224,A17,https://doi.org/10.1038/nnano.2013.213,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A224,A17,5669,161709,49352,2658
A225,A17,https://doi.org/10.1038/nnano.2013.214,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A225,A17,5615,153620,46910,2631
A226,A17,https://doi.org/10.1038/nnano.2013.215,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A226,A17,5483,150166,54406,2345
A227,A17,https://doi.org/10.1038/nnano.2013.216,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A227,A17,5553,146440,50479,3828
A228,A17,https://doi.org/10.1038/nnano.2013.217,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A228,A17,5863,158221,47152,3955
A229,A17,https://doi.org/10.1038/nnano.2013.218,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,69,50~100,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A229,A17,5868,178347,42958,3880
A230,A17,https://doi.org/10.1038/nnano.2013.219,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A230,A17,6134,87271,64142,5676
A231,A17,https://doi.org/10.1038/nnano.2013.220,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A231,A17,8159,92179,63791,6634
A232,A17,https://doi.org/10.1038/nnano.2013.221,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A232,A17,9919,110443,52030,7428
A233,A17,https://doi.org/10.1038/nnano.2013.222,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A233,A17,9615,153378,48897,5728
A234,A17,https://doi.org/10.1038/nnano.2013.223,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A234,A17,9948,148351,44685,6924
A235,A17,https://doi.org/10.1038/nnano.2013.224,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A235,A17,10001,142436,45961,6355
A236,A17,https://doi.org/10.1038/nnano.2013.225,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A236,A17,10712,128625,38155,7193
A237,A17,https://doi.org/10.1038/nnano.2013.226,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A237,A17,10546,159330,35565,7087
A238,A17,https://doi.org/10.1038/nnano.2013.227,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,75,50~100,Human Plasma,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A238,A17,8988,160950,31572,7797
A239,A17,https://doi.org/10.1038/nnano.2013.228,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A239,A17,8610,58115,54830,5691
A240,A17,https://doi.org/10.1038/nnano.2013.229,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A240,A17,8334,54295,53790,4930
A241,A17,https://doi.org/10.1038/nnano.2013.230,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A241,A17,9307,60682,49130,5333
A242,A17,https://doi.org/10.1038/nnano.2013.231,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A242,A17,11785,56483,61347,5465
A243,A17,https://doi.org/10.1038/nnano.2013.232,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A243,A17,11729,75230,55294,4844
A244,A17,https://doi.org/10.1038/nnano.2013.233,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A244,A17,11336,65222,27705,4949
A245,A17,https://doi.org/10.1038/nnano.2013.234,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A245,A17,11669,54682,34586,10688
A246,A17,https://doi.org/10.1038/nnano.2013.235,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A246,A17,9808,139619,34251,7503
A247,A17,https://doi.org/10.1038/nnano.2013.236,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,NH2,Amines,Positive,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,172,>150,Human Plasma,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A247,A17,9021,128116,21889,7400
A248,A17,https://doi.org/10.1038/nnano.2013.237,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A248,A17,6971,79646,61145,5285
A249,A17,https://doi.org/10.1038/nnano.2013.238,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A249,A17,5922,72147,61824,3825
A250,A17,https://doi.org/10.1038/nnano.2013.239,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A250,A17,7274,72166,49807,6213
A251,A17,https://doi.org/10.1038/nnano.2013.240,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A251,A17,10030,84369,44944,6585
A252,A17,https://doi.org/10.1038/nnano.2013.241,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A252,A17,10543,67900,48168,7368
A253,A17,https://doi.org/10.1038/nnano.2013.242,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A253,A17,10897,83938,43309,7325
A254,A17,https://doi.org/10.1038/nnano.2013.243,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A254,A17,11634,70419,36083,8194
A255,A17,https://doi.org/10.1038/nnano.2013.244,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A255,A17,10675,83157,35829,8990
A256,A17,https://doi.org/10.1038/nnano.2013.245,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,180,>150,Human Plasma,-28,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A256,A17,11417,88186,33961,8532
A257,A17,https://doi.org/10.1038/nnano.2013.246,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,0.5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A257,A17,7423,82636,49914,5337
A258,A17,https://doi.org/10.1038/nnano.2013.247,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,2,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A258,A17,7886,64023,66953,5307
A259,A17,https://doi.org/10.1038/nnano.2013.248,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,5,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A259,A17,7887,63602,65887,4144
A260,A17,https://doi.org/10.1038/nnano.2013.249,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,15,<30,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A260,A17,9390,75155,42679,5075
A261,A17,https://doi.org/10.1038/nnano.2013.250,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,30,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A261,A17,9670,84544,34976,4017
A262,A17,https://doi.org/10.1038/nnano.2013.251,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,60,30~60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A262,A17,13111,98068,31606,5686
A263,A17,https://doi.org/10.1038/nnano.2013.252,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,120,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A263,A17,13443,101294,30812,8107
A264,A17,https://doi.org/10.1038/nnano.2013.253,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,240,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A264,A17,12330,99463,31149,7594
A265,A17,https://doi.org/10.1038/nnano.2013.254,Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology,2013,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,Human Plasma,158,>150,Human Plasma,-21,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,60,ug,Not Reported,0.06,0~5,480,>60,N,37,DG Centrifugation,15300,4,20,3,in vitro,Human,ppm,4,A265,A17,13746,96776,21822,8779
A284,A23,https://doi.org/10.1021/nn201950e,Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,9.6,<50,PBS,-11,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,mL/m^2 (total particle-surface area to plasma concentration ),500,Not Reported,Not Reported,60,30~60,N,4,Centrifugation,12000,4,10,3,in vitro,Human,ppm,4,A284,A23,848,3388,599,2764
A285,A23,https://doi.org/10.1021/nn201950e,Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,15.7,<50,PBS,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,4,Centrifugation,12000,4,10,3,in vitro,Human,ppm,4,A285,A23,3574,30875,84374,15300
A286,A23,https://doi.org/10.1021/nn201950e,Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,54.9,50~100,PBS,-32,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,4,Centrifugation,12000,4,10,3,in vitro,Human,ppm,4,A286,A23,12741,65680,45778,10791
A287,A23,https://doi.org/10.1021/nn201950e,Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,12.5,<50,PBS,-11,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,4,Centrifugation,12000,4,10,3,in vitro,Human,ppm,4,A287,A23,848,3388,599,2764
A288,A23,https://doi.org/10.1021/nn201950e,Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,17.6,<50,PBS,-25,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,4,Centrifugation,12000,4,10,3,in vitro,Human,ppm,4,A288,A23,3574,30875,84374,15300
A289,A23,https://doi.org/10.1021/nn201950e,Nanoparticle Size Is a Critical Physicochemical Determinant of the Human Blood Plasma Corona: A Comprehensive Quantitative Proteomic Analysis,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,71.3,50~100,PBS,-32,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,4,Centrifugation,12000,4,10,3,in vitro,Human,ppm,4,A289,A23,12741,65680,45778,10791
A290,A24,https://doi.org/10.1002/adbi.201800221,Effect of Glucose on Liposome–Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations,2018,HSPC-Chol,DPSE-MPEG,Lipid,Neutral,Organic,Lipid,56.2:38.5:5.3,Sphere,DLS,DI-H2O,109.2,100~150,DI-H2O,-24,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1,<30,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,1,A290,A24,1.9,0,0,0
A291,A24,https://doi.org/10.1002/adbi.201800221,Effect of Glucose on Liposome–Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations,2018,HSPC-Chol,DPSE-MPEG,Lipid,Neutral,Organic,Lipid,56.2:38.5:5.3,Sphere,DLS,DI-H2O,102.5,100~150,DI-H2O,-23.9,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Glucose,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1,<30,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,2,A291,A24,2.1,0,1.4,0
A292,A24,https://doi.org/10.1002/adbi.201800221,Effect of Glucose on Liposome–Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations,2018,HSPC-Chol,DPSE-MPEG,Lipid,Neutral,Organic,Lipid,56.2:38.5:5.3,Sphere,DLS,DI-H2O,106,100~150,DI-H2O,-23.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Glucose,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1,<30,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,1,A292,A24,1.9,0,0,0
A293,A24,https://doi.org/10.1002/adbi.201800221,Effect of Glucose on Liposome–Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations,2018,DSPC-Chol,DSPE-MPEG,Lipid,Neutral,Organic,Lipid,215:143:1,Sphere,DLS,DI-H2O,171.2,>150,DI-H2O,-16.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1,<30,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,2,A293,A24,1.8,0,1.1,0
A294,A24,https://doi.org/10.1002/adbi.201800221,Effect of Glucose on Liposome–Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations,2018,DSPC-Chol,DSPE-MPEG,Lipid,Neutral,Organic,Lipid,215:143:1,Sphere,DLS,DI-H2O,174.1,>150,DI-H2O,-16.9,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Glucose,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1,<30,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,1,A294,A24,1.5,0,0,0
A295,A24,https://doi.org/10.1002/adbi.201800221,Effect of Glucose on Liposome–Plasma Protein Interactions: Relevance for the Physiological Response of Clinically Approved Liposomal Formulations,2018,DSPC-Chol,DSPE-MPEG,Lipid,Neutral,Organic,Lipid,215:143:1,Sphere,DLS,DI-H2O,155.8,>150,DI-H2O,-10.6,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Glucose,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1,<30,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,2,A295,A24,1.5,0,1.1,0
A296,A25,https://doi.org/10.1021/la401192x,Time Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery,2013,DC-Chol,DOPE,Lipid,Neutral,Organic,Lipid,0:1:2,Sphere,DLS,Human Plasma,250,>150,Human Plasma,-14,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1,<30,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,4,A296,A25,1.698886657,0.076371342,0.382055815,0.558032418
A297,A25,https://doi.org/10.1021/la401192x,Time Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery,2013,DC-Chol,DOPE,Lipid,Neutral,Organic,Lipid,0:1:2,Sphere,DLS,Human Plasma,450,>150,Human Plasma,-14,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,30,30~60,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,4,A297,A25,1.848981555,0.071315821,0.287378536,0.515165287
A298,A25,https://doi.org/10.1021/la401192x,Time Evolution of Nanoparticle–Protein Corona in Human Plasma: Relevance for Targeted Drug Delivery,2013,DC-Chol,DOPE,Lipid,Neutral,Organic,Lipid,1:2,Sphere,DLS,Human Plasma,470,>150,Human Plasma,-12,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,4,A298,A25,2.131817924,0.089477599,0.352124975,0.64406029
A299,A26,https://doi.org/10.1080/17435390.2017.1314036,"Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells",2017,Au,Polyethyleneimine,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,39.7,<50,DI-H2O,63.1,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,250,µg/mL,Not Reported,Not Reported,Not Reported,1440,>60,Y,37,Centrifugation,20000,20,30,Not Reported,in vitro,Human,%-RPA,3,A299,A26,1.898746214,0,0.366807396,0.951066555
A300,A26,https://doi.org/10.1080/17435390.2017.1314036,"Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells",2017,Au,Polyethyleneimine,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,82.3,50~100,DI-H2O,69.3,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,250,µg/mL,Not Reported,Not Reported,Not Reported,1440,>60,Y,37,Centrifugation,20000,20,30,Not Reported,in vitro,Human,%-RPA,3,A300,A26,1.008152346,0,0.259678543,1.041511599
A301,A26,https://doi.org/10.1080/17435390.2017.1314036,"Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells",2017,Au,Lipoic Acid,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,TEM,N/A,40.2,<50,DI-H2O,-73.3,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,250,µg/mL,Not Reported,Not Reported,Not Reported,1440,>60,Y,37,Centrifugation,20000,20,30,Not Reported,in vitro,Human,%-RPA,3,A301,A26,0.988465103,0,0.190955646,1.069800196
A302,A26,https://doi.org/10.1080/17435390.2017.1314036,"Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells",2017,Au,Lipoic Acid,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,TEM,N/A,81.8,50~100,DI-H2O,-43.9,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,250,µg/mL,Not Reported,Not Reported,Not Reported,1440,>60,Y,37,Centrifugation,20000,20,30,Not Reported,in vitro,Human,%-RPA,3,A302,A26,1.105280656,0,0.379595632,1.184144719
A303,A26,https://doi.org/10.1080/17435390.2017.1314036,"Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells",2017,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,41.5,<50,DI-H2O,-10.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,250,µg/mL,Not Reported,Not Reported,Not Reported,1440,>60,Y,37,Centrifugation,20000,20,30,Not Reported,in vitro,Human,%-RPA,3,A303,A26,1.211841945,0,0.156072319,0.834627456
A304,A26,https://doi.org/10.1080/17435390.2017.1314036,"Surface chemistry of gold nanoparticles determines the biocorona composition impacting cellular uptake, toxicity and gene expression profiles in human endothelial cells",2017,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,81.7,50~100,DI-H2O,-12.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,250,µg/mL,Not Reported,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,20,30,Not Reported,in vitro,Human,%-RPA,3,A304,A26,1.408861658,0,0.136084768,1.29376016
A305,A27,https://doi.org/10.1021/ja107583h,Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles,2011,Latex,PS-Sulfonate,Polymeric,Negative,Organic,Latex,N/A,Sphere,DLS,PBS,244.5,>150,PBS,-43.4,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,10,<50,1.25,mg/mL,Not Reported,Not Reported,Not Reported,60,30~60,N,0,Centrifugation,Not Reported,4,3,3,in vitro,Human,%-RPA,3,A305,A27,0.559,0,0.88,0.752
A306,A27,https://doi.org/10.1021/ja107583h,Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles,2011,Latex,PS-Sulfonate,Polymeric,Negative,Organic,Latex,N/A,Sphere,DLS,PBS,255.5,>150,PBS,-43.4,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,1.25,mg/mL,Not Reported,Not Reported,Not Reported,60,30~60,N,0,Centrifugation,Not Reported,4,3,3,in vitro,Human,%-RPA,3,A306,A27,0.173,0,0.52,0.731
A307,A27,https://doi.org/10.1021/ja107583h,Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,205,>150,PBS,-25.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,10,<50,1.25,mg/mL,Not Reported,Not Reported,Not Reported,60,30~60,N,0,Centrifugation,Not Reported,4,3,3,in vitro,Human,%-RPA,4,A307,A27,3.129,0.96,0.04,0.131
A308,A27,https://doi.org/10.1021/ja107583h,Physical-Chemical Aspects of Protein Corona: Relevance to in Vitro and in Vivo Biological Impacts of Nanoparticles,2011,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,205,>150,PBS,-25.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,1.25,mg/mL,Not Reported,Not Reported,Not Reported,60,30~60,N,0,Centrifugation,Not Reported,4,3,3,in vitro,Human,%-RPA,4,A308,A27,3.866,0.91,0.25,0.06
A313,A29,https://doi.org/10.1002/anie.201409211,Spherical Nucleic Acid Nanoparticle Conjugates Enhance G-Quadruplex Formation and Increase Serum Protein Interactions,2014,G-Rich DNA,No Modification,No Modification,No Modification,Organic,DNA,N/A,Sphere,DLS,PBS,54,50~100,PBS,-21.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,10,<50,5,nM,Not Reported,Not Reported,Not Reported,1440,>60,Y,37,Centrifugation,Not Reported,Not Reported,Not Reported,3,in vitro,Human,# of peptides,4,A313,A29,16,130,71,12
A314,A29,https://doi.org/10.1002/anie.201409211,Spherical Nucleic Acid Nanoparticle Conjugates Enhance G-Quadruplex Formation and Increase Serum Protein Interactions,2014,Poly-T DNA,No Modification,No Modification,No Modification,Organic,DNA,N/A,Sphere,DLS,PBS,56,50~100,PBS,-23.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,10,<50,5,nM,Not Reported,Not Reported,Not Reported,1440,>60,Y,37,Centrifugation,Not Reported,Not Reported,Not Reported,3,in vitro,Human,# of peptides,4,A314,A29,15,63,31,11
A331,A31,https://doi.org/10.1016/j.colsurfb.2014.06.016,Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles,2014,Iron Oxide,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,TEM,N/A,30,<50,N/A,-29.9,-50~-10,Negative,0.41,>0.2,Human Plasma,None,N/A,100,50~100,0.2,%-w-w,Not Reported,2,0~5,60,30~60,Y,37,Magnetic Pulldown,Not Reported,Not Reported,Not Reported,3,in vitro,Human,%-RPA,4,A331,A31,5.47,0.53,2,0.88
A332,A31,https://doi.org/10.1016/j.colsurfb.2014.06.016,Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles,2014,Iron Oxide,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,TEM,N/A,225,>150,N/A,-23.4,-50~-10,Negative,0.38,>0.2,Human Plasma,None,N/A,100,50~100,0.2,%-w-w,Not Reported,2,0~5,60,30~60,Y,37,Magnetic Pulldown,Not Reported,Not Reported,Not Reported,3,in vitro,Human,%-RPA,4,A332,A31,4.27,0.14,1.57,1.53
A333,A31,https://doi.org/10.1016/j.colsurfb.2014.06.016,Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles,2014,Iron Oxide,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,TEM,N/A,375,>150,N/A,-24.3,-50~-10,Negative,0.44,>0.2,Human Plasma,None,N/A,100,50~100,0.2,%-w-w,Not Reported,2,0~5,60,30~60,Y,37,Magnetic Pulldown,Not Reported,Not Reported,Not Reported,3,in vitro,Human,%-RPA,4,A333,A31,8.21,0.3,2.65,0.76
A334,A32,https://doi.org/10.1021/la302446h,Surface Coatings Shape the Protein Corona of SPIONs with Relevance to Their Application in Vivo,2022,Iron Oxide,Citrate,Carboxylic Acids,Negative,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,85,50~100,DI-H2O,-8.9,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,PBS,10,<50,0.32,mg,5,0.32,0~5,60,30~60,N,25,Centrifugation,Not Reported,4,30,3,in vitro,Human,%-LFQ,3,A334,A32,1.78,2.52,1.37,0
A335,A32,https://doi.org/10.1021/la302446h,Surface Coatings Shape the Protein Corona of SPIONs with Relevance to Their Application in Vivo,2022,Iron Oxide,Citrate,Carboxylic Acids,Negative,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,85,50~100,DI-H2O,-29.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,0.32,mg,285,0.32,0~5,60,30~60,N,25,Centrifugation,Not Reported,4,30,3,in vitro,Human,%-LFQ,3,A335,A32,1.52,0.71,1.86,0
A336,A32,https://doi.org/10.1021/la302446h,Surface Coatings Shape the Protein Corona of SPIONs with Relevance to Their Application in Vivo,2022,Iron Oxide,Oleate,Carboxylic Acids,Negative,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,81,50~100,DI-H2O,-7.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,PBS,10,<50,0.32,mg,5,0.32,0~5,60,30~60,N,25,Centrifugation,Not Reported,4,30,3,in vitro,Human,%-LFQ,4,A336,A32,3.54,0.32,1.37,2.44
A337,A32,https://doi.org/10.1021/la302446h,Surface Coatings Shape the Protein Corona of SPIONs with Relevance to Their Application in Vivo,2022,Iron Oxide,Oleate,Carboxylic Acids,Negative,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,81,50~100,DI-H2O,-10.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,55,50~100,0.32,mg,285,0.32,0~5,60,30~60,N,25,Centrifugation,Not Reported,4,30,3,in vitro,Human,%-LFQ,4,A337,A32,4.71,1.42,1.07,3.24
A338,A33,https://doi.org/10.1016/j.jcis.2021.11.140,Probing the glycans accessibility in the nanoparticle biomolecular corona,2022,Au,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,TEM,PBS,60,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Human Plasma,None,PBS,10,<50,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,6000,4,15,2,in vitro,Human,%-LFQ,4,A338,A33,12.222598,7.121901558,7.409921688,0.657206602
A339,A33,https://doi.org/10.1016/j.jcis.2021.11.140,Probing the glycans accessibility in the nanoparticle biomolecular corona,2022,Au,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,TEM,PBS,60,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Human Plasma,None,PBS,80,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,6000,4,15,2,in vitro,Human,%-LFQ,4,A339,A33,13.63046034,9.756334778,5.330938306,0.946119082
A340,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-30,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A340,A34,3.231,0.741,1.079,0.227
A341,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,Acrylic Acid,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-29,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A341,A34,3.326,0.774,1.192,0.242
A342,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,2-Methyl-2-Oxazoline,Small Hydrocarbons,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A342,A34,4.476,0.907,0.596,0.434
A343,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,"1,7-Octadiene",Small Hydrocarbons,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A343,A34,5.5,0.807,0.537,0.814
A344,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,Allylamine,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,2,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A344,A34,5.969,0.708,0.633,1.046
A345,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-30,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A345,A34,4.891,0.915,0.746,0.41
A346,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,Acrylic Acid,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-29,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A346,A34,2.713,0.897,1.195,0.245
A347,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,2-Methyl-2-Oxazoline,Small Hydrocarbons,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-18,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A347,A34,4.285,0.889,0.792,0.576
A348,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,"1,7-Octadiene",Small Hydrocarbons,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,-15,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A348,A34,4.519,0.734,0.642,1.115
A349,A34,https://doi.org/10.3390/nano12040682,Nanoparticles Surface Chemistry Influence on Protein Corona Composition and Inflammatory Responses,2021,Silica,Allylamine,Amines,Positive,Inorganic,Silica,N/A,Sphere,TEM,N/A,20,<50,NaCl,2,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,1,%-w-v,1000,1,0~5,60,30~60,Y,37,Centrifugation,20000,4,60,4,in vitro,Human,%-RPA,4,A349,A34,4.485,0.858,0.711,0.856
A354,A36,https://doi.org/10.1021/acs.biomac.5b00108,Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake,2015,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,102,100~150,KCl,-27,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,Not Reported,30,3,in vitro,Human,ppm,4,A354,A36,18354.43,9092.8,39211.64,165887.06
A355,A36,https://doi.org/10.1021/acs.biomac.5b00109,Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake,2015,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,100,100~150,KCl,8,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,Not Reported,30,3,in vitro,Human,ppm,4,A355,A36,8195.33,39241.81,121983.28,166996.41
A356,A36,https://doi.org/10.1021/acs.biomac.5b00110,Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake,2015,Polystyrene,Sulfonate,Sulfur-Based,Negative,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,119,100~150,KCl,-33,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,Not Reported,30,3,in vitro,Human,ppm,4,A356,A36,7964.4,25178.33,91583.83,174578.58
A357,A36,https://doi.org/10.1021/acs.biomac.5b00111,Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake,2015,Polystyrene,Phosphonate,Phosphorous-based,Negative,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,104,100~150,KCl,-60,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,Not Reported,30,3,in vitro,Human,ppm,4,A357,A36,5821.57,4735.88,57795.58,109050.28
A358,A36,https://doi.org/10.1021/acs.biomac.5b00112,Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake,2015,Polystyrene,phosphonate-Lutensol AT50,Phosphorous-based,Negative,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,109,100~150,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,Not Reported,30,3,in vitro,Human,ppm,4,A358,A36,8024.3,4243.27,45162.89,190072.47
A359,A36,https://doi.org/10.1021/acs.biomac.5b00113,Protein Corona of Nanoparticles: Distinct Proteins Regulate the Cellular Uptake,2015,Polystyrene,phosphonate-SDS,Phosphorous-based,Negative,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,104,100~150,KCl,-61,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5,mL/m^2,500,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,Not Reported,30,3,in vitro,Human,ppm,4,A359,A36,4951.66,3436.5,71399.81,154367.89
A363,A37,https://doi.org/10.1021/acs.biomac.8b00278,Denaturation via Surfactants Changes Composition of Protein Corona,2018,Polystyrene,Lutensol AT50,Surfactant,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,60,50~100,KCl,-8,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Trisodium Citrate,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A363,A37,2.881595407,0.011976967,0.283623173,40.07305887
A364,A37,https://doi.org/10.1021/acs.biomac.8b00278,Denaturation via Surfactants Changes Composition of Protein Corona,2018,Polystyrene,Lutensol AT50 + 0.01% CTMA-Cl,Surfactant,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,60,50~100,KCl,-8,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Trisodium Citrate,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A364,A37,5.52646902,0.009163109,0.350532577,49.73123056
A365,A37,https://doi.org/10.1021/acs.biomac.8b00278,Denaturation via Surfactants Changes Composition of Protein Corona,2018,Polystyrene,Lutensol AT50 + 0.1% CTMA-Cl,Surfactant,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,60,50~100,KCl,-8,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Trisodium Citrate,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A365,A37,8.827820176,0.015392022,0.29846987,27.85885226
A366,A37,https://doi.org/10.1021/acs.biomac.8b00278,Denaturation via Surfactants Changes Composition of Protein Corona,2018,Polystyrene,Lutensol AT50 + 0.2% CTMA-Cl,Surfactant,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,60,50~100,KCl,-8,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Trisodium Citrate,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A366,A37,5.764584789,0.255293712,0.148230833,12.97349806
A367,A37,https://doi.org/10.1021/acs.biomac.8b00278,Denaturation via Surfactants Changes Composition of Protein Corona,2018,Polystyrene,Lutensol AT50 + 0.3% CTMA-Cl,Surfactant,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,60,50~100,KCl,-8,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Trisodium Citrate,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A367,A37,3.982287847,0.394203152,0.110252051,10.3713056
A368,A37,https://doi.org/10.1021/acs.biomac.8b00278,Denaturation via Surfactants Changes Composition of Protein Corona,2018,Polystyrene,PEG,Polymeric,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,57,50~100,KCl,13,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,Trisodium Citrate,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A368,A37,4.641435594,0.190665017,0.062598648,32.66393712
A369,A37,https://doi.org/10.1021/acs.biomac.8b00278,Denaturation via Surfactants Changes Composition of Protein Corona,2018,Polystyrene,PEG + 0.3% CTMA-Cl,Polymeric,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,Not Reported,57,50~100,KCl,13,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,Trisodium Citrate,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A369,A37,4.186322708,0.418437975,0.071503619,10.97034111
A370,A38,https://doi.org/10.3390/nano12152661,Biomolecular Corona Stability in Association with Plasma Cholesterol Level ,2022,Silica,COOH,Carboxylic Acids,Negative,Inorganic,Silica,N/A,Sphere,DLS,PBS,100,100~150,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,21,10,1,in vitro,Human,Log2 Peptide Intensity,3,A370,A38,32.5,33.8,31.4,0
A371,A38,https://doi.org/10.3390/nano12152661,Biomolecular Corona Stability in Association with Plasma Cholesterol Level ,2022,Polystyrene,COOH,Carboxylic Acids,Negative,Inorganic,Polystyrene,N/A,Sphere,DLS,PBS,200,>150,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,21,10,1,in vitro,Human,Log2 Peptide Intensity,2,A371,A38,0,30.4,32.8,0
A394,A41,https://doi.org/10.1021/acschemneuro.8b00339,Brain Targeting by Liposome–Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells,2018,DOTAP,Cholesterol,Carboxylic Acids,Neutral,Organic,Lipid,N/A,Sphere,DLS,DI-H2O,251.16,>150,DI-H2O,-20.1,-50~-10,Negative,0.25,>0.2,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A394,A41,2.30455,1.38985,3.55759,1.01991
A395,A41,https://doi.org/10.1021/acschemneuro.8b00339,Brain Targeting by Liposome–Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells,2018,DOTAP,DOPE,Lipid,Neutral,Organic,Lipid,N/A,Sphere,DLS,DI-H2O,24.42,<50,DI-H2O,-17.8,-50~-10,Negative,0.15,0.1~0.2,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,3,A395,A41,1.59146,0.44076,0,4.28226
A396,A41,https://doi.org/10.1021/acschemneuro.8b00339,Brain Targeting by Liposome–Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells,2018,DC-Chol,DOPE,Lipid,Neutral,Organic,Lipid,N/A,Sphere,DLS,DI-H2O,288.37,>150,DI-H2O,-25.17,-50~-10,Negative,0.16,0.1~0.2,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A396,A41,1.37217,0.69714,2.61681,1.5424
A397,A41,https://doi.org/10.1021/acschemneuro.8b00339,Brain Targeting by Liposome–Biomolecular Corona Boosts Anticancer Efficacy of Temozolomide in Glioblastoma Cells,2018,DC-Chol,Cholesterol,Lipid,Neutral,Organic,Lipid,N/A,Sphere,DLS,DI-H2O,364.341,>150,DI-H2O,-21.93,-50~-10,Negative,0.19,0.1~0.2,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,61,>60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A397,A41,2.5106,1.45799,2.53395,1.11928
A403,A43,https://doi.org/10.1021/acs.biomac.9b00777,Timing of Heparin Addition to the Biomolecular Corona Influences the Cellular Uptake of Nanocarriers,2019,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,100,100~150,DI-H2O,0,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,4,A403,A43,1.978289724,0.035989075,0.131070481,10.70184548
A404,A43,https://doi.org/10.1021/acs.biomac.9b00777,Timing of Heparin Addition to the Biomolecular Corona Influences the Cellular Uptake of Nanocarriers,2019,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,100,100~150,DI-H2O,1,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,4,A404,A43,2.500688952,0.031159474,0.127063,8.45693543
A405,A43,https://doi.org/10.1021/acs.biomac.9b00777,Timing of Heparin Addition to the Biomolecular Corona Influences the Cellular Uptake of Nanocarriers,2019,Polystyrene,Citrate,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,100,100~150,DI-H2O,0.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,4,A405,A43,2.837378858,0.035540193,0.116602375,7.654923095
A406,A43,https://doi.org/10.1021/acs.biomac.9b00777,Timing of Heparin Addition to the Biomolecular Corona Influences the Cellular Uptake of Nanocarriers,2019,Polystyrene,Citrate,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,100,100~150,DI-H2O,0.3,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,Heparin,N/A,100,50~100,0.05,m^2,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,4,A406,A43,1.820326864,0.016174925,0.089281055,7.086426989
A407,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,Silica,PEG,Polymeric,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-13.4,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A407,A44,2.8792,0.2602,0.178,0.0853
A408,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,Silica,PEG,Polymeric,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-15.6,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A408,A44,1.1808,0.1591,0.2091,0.0775
A409,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,Silica,PEG,Polymeric,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-17.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A409,A44,0.6061,0.1112,0.2475,0.0379
A410,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,Silica,PEG,Polymeric,Neutral,Inorganic,Silica,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-26.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A410,A44,0.0141,0.0039,0.2601,0.0058
A411,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,PEG,No Modification,No Modification,No Modification,Organic,PEG,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-37.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A411,A44,0.0362,0.0769,1.0465,0.5043
A412,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,PEG,No Modification,No Modification,No Modification,Organic,PEG,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-37.8,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A412,A44,0.049,0.0544,1.0442,0.4706
A413,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,PEG,No Modification,No Modification,No Modification,Organic,PEG,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-38.6,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A413,A44,0.0403,0.0557,1.0162,0.3587
A414,A44,https://doi.org/10.1021/acsnano.1c01642,Influence of Poly(ethylene glycol) Molecular Architecture on Particle Assembly and Ex Vivo Particle–Immune Cell Interactions in Human Blood,2021,PEG,No Modification,No Modification,No Modification,Organic,PEG,N/A,Sphere,TEM,N/A,Not Reported,Not Reported,DI-H2O,-36.4,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,200000000,# of particles,300,Not Reported,Not Reported,60,30~60,Y,37,Solvent Wash,N/A,N/A,N/A,6,in vitro,Human,mol-%,4,A414,A44,0.0393,0.1059,0.9184,0.9384
A415,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Ag,No Modification,No Modification,No Modification,Inorganic,Metal,N/A,Sphere,TEM,N/A,49.3,<50,PBS,-8.05,-10~+10,Neutral,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,2,A415,A45,0,0,0.018490889,0.125640428
A416,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Ag,Sulfide,Sulfur-Based,Negative,Inorganic,Metal,N/A,Sphere,TEM,N/A,55.6,50~100,PBS,-19.55,-50~-10,Negative,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,2,A416,A45,0,0,0.044653872,0.162513518
A417,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Zinc Oxide,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,TEM,N/A,41.9,<50,PBS,-22.24,-50~-10,Negative,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,2,A417,A45,0,0,0.034514066,0.083740438
A418,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Zinc Oxide,Sulfide,Sulfur-Based,Negative,Inorganic,Metal Oxide,N/A,Sphere,TEM,N/A,71.4,50~100,PBS,-26.4,-50~-10,Negative,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,3,A418,A45,0.014880369,0,0.059459852,0.137006292
A419,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Ag,No Modification,No Modification,No Modification,Inorganic,Metal,N/A,Sphere,DLS,PBS,71.8,50~100,PBS,-8.05,-10~+10,Neutral,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,2,A419,A45,0,0,0.018490889,0.125640428
A420,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Ag,Sulfide,Sulfur-Based,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,223.4,>150,PBS,-19.55,-50~-10,Negative,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,2,A420,A45,0,0,0.044653872,0.162513518
A421,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Zinc Oxide,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,PBS,558.5,>150,PBS,-22.24,-50~-10,Negative,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,2,A421,A45,0,0,0.034514066,0.083740438
A422,A45,https://doi.org/10.1021/acs.est.9b04332,Sulfidation of Ag and ZnO Nanomaterials Significantly Affects Protein Corona Composition: Implications for Human Exposure to Environmentally Aged Nanomaterials,2019,Zinc Oxide,Sulfide,Sulfur-Based,Negative,Inorganic,Metal Oxide,N/A,Sphere,DLS,PBS,654.3,>150,PBS,-26.4,-50~-10,Negative,Not Reported,Not Reported,Human BALF,None,N/A,100,50~100,1,mM,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,16000,4,20,3,in vitro,Human,%-RPA,3,A422,A45,0.014880369,0,0.059459852,0.137006292
A424,A46,https://doi.org/10.1038/s41467-018-04009-x,Biological recognition of graphene nanoflakes,2018,Graphite,No Modification,No Modification,No Modification,Carbon-Based,Graphene,N/A,Flakes,DCS,N/A,250,>150,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,1700,Not Reported,60,3,in vitro,Human,%-RPA,4,A424,A46,4.394408504,0.375541987,2.414117269,1.627722118
A425,A47,https://doi.org/10.1038/nnano.2015.330,Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers,2016,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,106,100~150,DI-H2O,46,+10~+50,Positive,2.5,>0.2,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,Not Reported,60,3,in vitro,Human,%-RPA,3,A425,A47,0.22358749,0,0.099226592,3.554224918
A426,A47,https://doi.org/10.1038/nnano.2015.330,Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers,2016,Polystyrene,PEG,Polymeric,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,117,100~150,DI-H2O,15,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,Not Reported,60,3,in vitro,Human,%-RPA,4,A426,A47,1.045204003,0.006207114,0.13768399,45.03415698
A427,A47,https://doi.org/10.1038/nnano.2015.330,Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers,2016,Polystyrene,PEG,Polymeric,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,119,100~150,DI-H2O,8,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,Not Reported,60,3,in vitro,Human,%-RPA,4,A427,A47,0.798616687,0.003359216,0.225731165,42.12340938
A428,A47,https://doi.org/10.1038/nnano.2015.330,Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers,2016,Polystyrene,Poly(Ethyl Ethylene Phosphate),Polymeric,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,117,100~150,DI-H2O,-9,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,Not Reported,60,3,in vitro,Human,%-RPA,4,A428,A47,0.603551065,0.006174408,0.091737272,67.47549672
A429,A47,https://doi.org/10.1038/nnano.2015.330,Protein adsorption is required for stealth effect of poly(ethylene glycol)- and poly(phosphoester)-coated nanocarriers,2016,Polystyrene,Poly(Ethyl Ethylene Phosphate),Polymeric,Neutral,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,122,100~150,DI-H2O,-10,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,Not Reported,60,3,in vitro,Human,%-RPA,4,A429,A47,0.44030133,0.003268908,0.087988508,69.23007968
A430,A48,https://doi.org/10.1016/j.bbagen.2017.03.010,Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells,2017,ADM70,No Modification,No Modification,No Modification,Organic,DNA,Not Reported,Sphere,DLS,Human Plasma,114,100~150,Human Plasma,29.8,+10~+50,Positive,0.21,>0.2,Human Plasma,None,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,3,A430,A48,3.07,0,2.37,1.25
A431,A48,https://doi.org/10.1016/j.bbagen.2017.03.010,Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells,2017,ADM105,No Modification,No Modification,No Modification,Organic,DNA,Not Reported,Sphere,DLS,Human Plasma,149,100~150,Human Plasma,31.7,+10~+50,Positive,0.41,>0.2,Human Plasma,None,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,3,A431,A48,2.7,0,1.63,2.02
A432,A48,https://doi.org/10.1016/j.bbagen.2017.03.010,Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells,2017,ADM105,pDNA,Other,Negative,Organic,DNA,Not Reported,Sphere,DLS,Human Plasma,191,>150,Human Plasma,-16.3,-50~-10,Negative,0.64,>0.2,Human Plasma,None,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,3,A432,A48,1.97,0,1.57,1.54
A433,A48,https://doi.org/10.1016/j.bbagen.2017.03.010,Biophysics and protein corona analysis of Janus cyclodextrin-DNA nanocomplexes. Efficient cellular transfection on cancer cells,2017,ADM70,pDNA,Other,Negative,Organic,DNA,Not Reported,Sphere,DLS,Human Plasma,153,>150,Human Plasma,-17.4,-50~-10,Negative,0.34,>0.2,Human Plasma,None,N/A,50,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,14000,Not Reported,15,3,in vitro,Human,%-RPA,3,A433,A48,2.14,0,3.84,0.92
A434,A49,https://doi.org/10.1039/C5NR01970B,Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials,2015,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,73.7,50~100,PBS,-43.5,-50~-10,Negative,0.06,0~0.1,Human Plasma,None,PBS,10,<50,40,mg/L,Not Reported,0.007,0~5,60,30~60,N,25,Not Reported,N/A,N/A,N/A,N/A,in vitro,Human,%-RPA,4,A434,A49,3.8981574,0.5479104,0.3799306,0.2297801
A435,A49,https://doi.org/10.1039/C5NR01970B,Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials,2015,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,73.7,50~100,PBS,-43.5,-50~-10,Negative,0.06,0~0.1,Human Plasma,None,PBS,25,<50,40,mg/L,Not Reported,0.007,0~5,60,30~60,N,25,Not Reported,N/A,N/A,N/A,N/A,in vitro,Human,%-RPA,4,A435,A49,1.39,3.82,0.27,0.05
A436,A49,https://doi.org/10.1039/C5NR01970B,Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials,2015,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,73.7,50~100,PBS,-43.5,-50~-10,Negative,0.06,0~0.1,Human Plasma,None,PBS,55,50~100,40,mg/L,Not Reported,0.007,0~5,60,30~60,N,25,Not Reported,N/A,N/A,N/A,N/A,in vitro,Human,%-RPA,3,A436,A49,2.8564419,1.1685881,0.1489602,0
A437,A49,https://doi.org/10.1039/C5NR01970B,Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials,2015,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,73.7,50~100,PBS,-43.5,-50~-10,Negative,0.06,0~0.1,Human Plasma,None,PBS,75,50~100,40,mg/L,Not Reported,0.007,0~5,60,30~60,N,25,Not Reported,N/A,N/A,N/A,N/A,in vitro,Human,%-RPA,3,A437,A49,1.63,9.51,0.44,0
A438,A49,https://doi.org/10.1039/C5NR01970B,Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials,2015,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,116.3,100~150,PBS,-53.2,<-50,Negative,0.05,0~0.1,Human Plasma,None,PBS,10,<50,5,mg/L,Not Reported,0.0008775,0~5,60,30~60,N,25,Not Reported,N/A,N/A,N/A,N/A,in vitro,Human,%-RPA,2,A438,A49,0,0.05,0,0.13
A439,A49,https://doi.org/10.1039/C5NR01970B,Characterization of the bionano interface and mapping extrinsic interactions of the corona of nanomaterials,2015,Polystyrene,sulfate,Sulfur-Based,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,130,100~150,PBS,-61.2,<-50,Negative,0.09,0~0.1,Human Plasma,None,PBS,10,<50,1,mg/L,Not Reported,0.000175,0~5,60,30~60,N,25,Not Reported,N/A,N/A,N/A,N/A,in vitro,Human,%-RPA,3,A439,A49,0.09,0,0.03,0.53
A440,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sheet,DLS,DI-H2O,12,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,2,A440,A50,0,0.62,2.85,0
A441,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sheet,DLS,DI-H2O,12,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,3,A441,A50,0,0.29,1.32,0.36
A442,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sheet,DLS,DI-H2O,12,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,2,A442,A50,0,0.19,1.06,0
A443,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,3,A443,A50,1.62,0.43,2.43,0
A444,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,3,A444,A50,2.17,0.28,2.31,0
A445,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,4,A445,A50,2.54,0.26,1.89,0.75
A446,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,3,A446,A50,0,0.44,2.76,0.62
A447,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sheet,DLS,DI-H2O,12,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,1,A447,A50,0,0,8.82,0
A448,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sheet,DLS,DI-H2O,12,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,1,A448,A50,0,0,4.2,0
A449,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sheet,DLS,DI-H2O,12,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,1,A449,A50,0,0,2.42,0
A450,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sheet,DLS,DI-H2O,12,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,1,A450,A50,0,0,2.86,0
A451,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,2,A451,A50,6.917,0,2.227,0
A452,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,3,A452,A50,5.848,0.41,4.519,0
A453,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,3,A453,A50,6.072,0.426,6.452,0
A454,A50,https://doi.org/10.1039/C3TX50023C,Corona protein composition and cytotoxicity evaluation of ultra-small zeolites synthesized from template free precursor suspensions,2013,Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,DI-H2O,13,<50,DI-H2O,-35,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,100,mg/L,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,Not Reported,Not Reported,20,5,in vitro,Human,%-RPA,3,A454,A50,5.203,0.547,5.026,0
A455,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,102,100~150,Not Reported,54.3,>+50,Positive,0.243,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A455,A51,1.74004,0.45228,5.31456,0.82649
A456,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,102,100~150,Not Reported,54.3,>+50,Positive,0.243,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A456,A51,1.68042,0.54471,5.04491,0.77782
A457,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,102,100~150,Not Reported,54.3,>+50,Positive,0.243,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A457,A51,1.80657,0.51947,4.6858,0.67514
A458,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,109,100~150,Not Reported,56.3,>+50,Positive,0.212,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A458,A51,1.584980446,0.427838443,5.94,0.743810339
A459,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,109,100~150,Not Reported,56.3,>+50,Positive,0.212,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A459,A51,1.71076291,0.447482618,5.67,0.720079596
A460,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,109,100~150,Not Reported,56.3,>+50,Positive,0.212,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A460,A51,1.739281739,0.434894416,5.27,0.752166703
A461,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,105,100~150,Not Reported,60.5,>+50,Positive,0.239,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A461,A51,1.37687,0.31973,2.20764,0.42389
A462,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,105,100~150,Not Reported,60.5,>+50,Positive,0.239,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A462,A51,1.51562,0.35255,2.27723,0.43076
A463,A51,https://doi.org/10.1016/j.jprot.2012.01.003,Do plasma proteins distinguish between liposomes of varying charge density?,2012,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,Not Reported,Not Reported,105,100~150,Not Reported,60.5,>+50,Positive,0.239,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A463,A51,1.70674,0.34066,2.09583,0.48299
A464,A52,https://doi.org/10.1007/s11051-013-1498-4,Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles,2013,DOTAP-Chol,No Modification,No Modification,No Modification,Organic,Lipid,1:1:0,Sphere,DLS,DI-H2O,83.5,50~100,DI-H2O,50.5,>+50,Positive,0.293,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A464,A52,2.344904295,1.216126533,3.145329957,0.881134902
A465,A52,https://doi.org/10.1007/s11051-013-1498-4,Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles,2013,DOTAP-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,1:0:1,Sphere,DLS,DI-H2O,90.8,50~100,DI-H2O,51.2,>+50,Positive,0.225,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A465,A52,1.2126407,0.415674225,1.158719895,3.749091478
A466,A52,https://doi.org/10.1007/s11051-013-1498-4,Effect of DOPE and cholesterol on the protein adsorption onto lipid nanoparticles,2013,DOTAP,No Modification,No Modification,No Modification,Organic,Lipid,1:0:0,Sphere,DLS,DI-H2O,78.8,50~100,DI-H2O,55.7,>+50,Positive,0.205,>0.2,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,400,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,10,3,in vitro,Human,%-RPA,4,A466,A52,0.935250086,0.655607203,2.609528957,2.312431531
A467,A53,https://doi.org/10.1039/C3NR05559K,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,2014,DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG ,PEG,Polymeric,No Modification,Organic,Lipid,1:1:1:0.7:0.3,Sphere,DLS,DI-H2O,103.2,100~150,DI-H2O,11.3,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A467,A53,1.361390612,0.573624644,4.63909205,0.656833048
A468,A53,https://doi.org/10.1039/C3NR05559K,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,2014,DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG ,PEG,Polymeric,No Modification,Organic,Lipid,1:1:1:0.7:0.3,Sphere,DLS,DI-H2O,118.7,100~150,DI-H2O,15.5,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A468,A53,1.866024187,0.962400464,1.687038452,0.932103611
A469,A53,https://doi.org/10.1039/C3NR05559K,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,2014,DOTAP-DOPC-DC-Chol-DOPE/DOPE-PEG ,PEG,Polymeric,No Modification,Organic,Lipid,1:1:1:0.7:0.3,Sphere,DLS,DI-H2O,116.9,100~150,DI-H2O,18.3,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A469,A53,1.945416115,0.811941848,5.209821009,0.843658071
A470,A53,https://doi.org/10.1039/C3NR05559K,Effect of polyethyleneglycol (PEG) chain length on the bio-nano- interactions between PEGylated lipid nanoparticles and biological fluids: From nanostructure to uptake in cancer cells,2014,DOTAP-DOPC-DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,1:1:1:1,Sphere,DLS,DI-H2O,86,50~100,DI-H2O,27.4,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,Not Reported,1,0~5,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A470,A53,2.565463553,0.806464886,1.911206482,1.245304589
A471,A54,https://doi.org/10.1016/j.biomaterials.2014.04.067,The effect of protein corona composition on the interaction of carbon nanotubes with human blood platelets,2014,Carbon,COOH,Carboxylic Acids,Negative,Carbon-Based,Carbon,N/A,Nanotube,DLS,Other Buffer,80,50~100,Other Buffer,-57,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,PBS,91,50~100,0.1,mg/mL,1000,0.1,0~5,60,30~60,N,25,Centrifugation,10000,Not Reported,Not Reported,2,in vitro,Human,%-RPA,1,A471,A54,0,0,0.087964227,0
A475,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,53.3,50~100,Human Plasma,-21.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A475,A56,1.21710808,0.069629537,0.219779485,0.788683733
A476,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,53.3,50~100,Human Plasma,-21.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A476,A56,1.008980937,0.058072384,0.178470745,0.64440471
A477,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,58.1,50~100,Human Plasma,-26.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A477,A56,0.952550945,0.056514427,0.170541092,0.611397751
A478,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,58.1,50~100,Human Plasma,-26.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A478,A56,1.014901311,0.057120443,0.178910998,0.633566143
A479,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,RPMI,93.5,50~100,RPMI,-6.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A479,A56,1.21710808,0.069629537,0.219779485,0.788683733
A480,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,RPMI,93.5,50~100,RPMI,-6.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A480,A56,1.008980937,0.058072384,0.178470745,0.64440471
A481,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,RPMI,115.3,100~150,RPMI,-9.9,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A481,A56,0.952550945,0.056514427,0.170541092,0.611397751
A482,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,RPMI,115.3,100~150,RPMI,-9.9,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A482,A56,1.014901311,0.057120443,0.178910998,0.633566143
A483,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,58.6,50~100,DI-H2O,-25.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A483,A56,1.21710808,0.069629537,0.219779485,0.788683733
A484,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,58.6,50~100,DI-H2O,-25.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A484,A56,1.008980937,0.058072384,0.178470745,0.64440471
A485,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,26.6,<50,DI-H2O,-37,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A485,A56,0.952550945,0.056514427,0.170541092,0.611397751
A486,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,26.6,<50,DI-H2O,-37,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A486,A56,1.014901311,0.057120443,0.178910998,0.633566143
A487,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,99.5,50~100,PBS,-6.4,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A487,A56,1.21710808,0.069629537,0.219779485,0.788683733
A488,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,99.5,50~100,PBS,-6.4,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A488,A56,1.008980937,0.058072384,0.178470745,0.64440471
A489,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,654.7,>150,PBS,-16.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A489,A56,0.952550945,0.056514427,0.170541092,0.611397751
A490,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,654.7,>150,PBS,-16.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A490,A56,1.014901311,0.057120443,0.178910998,0.633566143
A491,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,21.6,<50,Human Plasma,-21.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A491,A56,1.21710808,0.069629537,0.219779485,0.788683733
A492,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,TEM,N/A,24.3,<50,Human Plasma,-26.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A492,A56,1.008980937,0.058072384,0.178470745,0.64440471
A493,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,21.6,<50,RPMI,-6.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A493,A56,0.952550945,0.056514427,0.170541092,0.611397751
A494,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,TEM,N/A,24.3,<50,RPMI,-9.9,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A494,A56,1.014901311,0.057120443,0.178910998,0.633566143
A495,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,21.6,<50,DI-H2O,-25.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A495,A56,1.21710808,0.069629537,0.219779485,0.788683733
A496,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,TEM,N/A,24.3,<50,DI-H2O,-37,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A496,A56,1.008980937,0.058072384,0.178470745,0.64440471
A497,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,TEM,N/A,21.6,<50,PBS,-6.4,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,180,>60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A497,A56,0.952550945,0.056514427,0.170541092,0.611397751
A498,A56,https://doi.org/10.1038/srep25518,An Evaluation of Blood Compatibility of Silver Nanoparticles,2016,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,TEM,N/A,24.3,<50,PBS,-16.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,19000,4,20,3,in vitro,Human,%-RPA,4,A498,A56,1.014901311,0.057120443,0.178910998,0.633566143
A499,A57,https://doi.org/10.1021/acsnano.6b07933,Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles,2017,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,118,100~150,PBS,-13.5,-50~-10,Negative,0.02,0~0.1,Human Plasma,None,PBS,10,<50,1,mg,1000,1,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,20,3,in vitro,Human,%-RPA,3,A499,A57,2.81,1.65,1.71,0
A500,A57,https://doi.org/10.1021/acsnano.6b07933,Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles,2017,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,118,100~150,PBS,-13.5,-50~-10,Negative,0.02,0~0.1,Human Plasma,None,PBS,30,<50,1,mg,1000,1,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,20,3,in vitro,Human,%-RPA,3,A500,A57,2.93,0.99,1.72,0
A501,A57,https://doi.org/10.1021/acsnano.6b07933,Identification of Receptor Binding to the Biomolecular Corona of Nanoparticles,2017,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,118,100~150,PBS,-13.5,-50~-10,Negative,0.02,0~0.1,Human Plasma,None,PBS,50,50~100,1,mg,1000,1,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,20,3,in vitro,Human,%-RPA,3,A501,A57,2.57,1.18,2.11,0
A508,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,55.78,50~100,DI-H2O,-25.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A508,A60,3.07,0.547,0.35,0.18
A509,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Au,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,27.11,<50,DI-H2O,-24.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A509,A60,1.23,0.235,7.913,0.196
A510,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Au,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,30.03,<50,DI-H2O,-24.3,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A510,A60,1.57,0.091,6.333,0.17
A511,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Ag,Branched polyethyleneimine ,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,43.14,<50,DI-H2O,53.95,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A511,A60,0.87,0.203,1.19,1.36
A512,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,26.61,<50,DI-H2O,-36.95,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A512,A60,12.4,0.294,1.62,0.422
A513,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Au,Branched polyethyleneimine ,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,DI-H2O,37.2,<50,DI-H2O,47,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A513,A60,0.993,0.77,1.42,1.58
A514,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Ag,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,75.36,50~100,Human Plasma,-21.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A514,A60,3.07,0.547,0.35,0.18
A515,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Au,Polyvinyl Pyrrolidone,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,47.02,<50,Human Plasma,-23.97,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A515,A60,1.23,0.235,7.913,0.196
A516,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Au,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,56.6,50~100,Human Plasma,-24.97,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A516,A60,1.57,0.091,6.333,0.17
A517,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Ag,Branched polyethyleneimine ,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,301.67,>150,Human Plasma,-25.7,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A517,A60,0.87,0.203,1.19,1.36
A518,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,58.1,50~100,Human Plasma,-26.13,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A518,A60,12.4,0.294,1.62,0.422
A519,A60,https://doi.org/10.1016/j.colsurfb.2017.01.037,Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns,2017,Au,Branched polyethyleneimine ,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,Human Plasma,295.2,>150,Human Plasma,-26.9,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,5.55,ml/m^2,Not Reported,Not Reported,Not Reported,60,30~60,N,37,SC Centrifugation,19000,4,20,6,in vitro,Human,%-RPA,4,A519,A60,0.993,0.77,1.42,1.58
A520,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DOTAP-Chol,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,PBS,83.5,50~100,PBS,50.5,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A520,A61,2.344904295,1.216126533,3.145329957,0.881134902
A521,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DOTAP-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,PBS,90.8,50~100,PBS,51.2,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A521,A61,1.2126407,0.415674225,1.158719895,3.749091478
A522,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,Chol-DC,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,PBS,85.6,50~100,PBS,55.6,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A522,A61,0.623111613,0.531995744,1.562034114,0.481040786
A523,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DOTAP,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,PBS,78.8,50~100,PBS,55.7,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A523,A61,0.935250086,0.655607203,2.609528957,2.312431531
A524,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,1:1:1,Sphere,DLS,PBS,119.2,100~150,PBS,56.3,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A524,A61,2.687683595,1.611025542,2.295573697,1.179319454
A525,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,Chol-DC,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,PBS,99.6,50~100,PBS,59.2,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A525,A61,1.01010101,0.813953488,2.389912194,0.735992403
A526,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DOTAP,No Modification,No Modification,No Modification,Organic,Lipid,1,Sphere,DLS,Human Plasma,156.5,>150,Human Plasma,-1.5,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A526,A61,0.935250086,0.655607203,2.609528957,2.312431531
A527,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,Chol-DC,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,Human Plasma,220,>150,Human Plasma,-10.6,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A527,A61,1.01010101,0.813953488,2.389912194,0.735992403
A528,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,Chol-DC,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,Human Plasma,210,>150,Human Plasma,-11.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A528,A61,0.623111613,0.531995744,1.562034114,0.481040786
A529,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DC-Chol-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,1:1:1,Sphere,DLS,Human Plasma,250,>150,Human Plasma,-11.4,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A529,A61,2.687683595,1.611025542,2.295573697,1.179319454
A530,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DOTAP-DOPE,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,Human Plasma,178.1,>150,Human Plasma,-2.1,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A530,A61,1.2126407,0.415674225,1.158719895,3.749091478
A531,A61,https://doi.org/10.1039/C4RA13335H,"Lipid composition: a ""key factor"" for the rational manipulation of the liposome-protein corona by liposome design",2015,DOTAP-Chol,No Modification,No Modification,No Modification,Organic,Lipid,1:1,Sphere,DLS,Human Plasma,187.4,>150,Human Plasma,-2.4,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A531,A61,2.344904295,1.216126533,3.145329957,0.881134902
A532,A62,https://doi.org/10.1039/C4TB01316F,The liposome-protein corona in mice and humans and its implications for in vivo delivery,2014,DOTAP,PEG,Polymeric,Neutral,Organic,Lipid,1:1,Sphere,DLS,Human Plasma,152.85,>150,Human Plasma,-13.74,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,Y,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A532,A62,1.401228726,0.180190156,0.94921946,0.497639173
A533,A62,https://doi.org/10.1039/C4TB01316F,The liposome-protein corona in mice and humans and its implications for in vivo delivery,2014,DOTAP-DSPC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,1:1:1,Sphere,DLS,Human Plasma,208,>150,Human Plasma,-15.7,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,200,0.2,0~5,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,15,3,in vitro,Human,%-RPA,4,A533,A62,0.897948722,0.619515,2.520445492,0.575608155
A537,A64,https://doi.org/10.1038/nnano.2015.47,Mapping protein binding sites on the biomolecular corona of nanoparticles,2015,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,PBS,220,>150,PBS,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,Transferrin-Depleted,N/A,80,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,60,30~60,N,25,Centrifugation,20000,Not Reported,10,6,in vitro,Human,%-RPA,2,A537,A64,2.1,0,0,0.7
A538,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,PEG,Polymeric,Neutral,Organic,Lipid,Not Reported,Sphere,DLS,PBS,103.2,100~150,PBS,9.9,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A538,A65,1.36,0,4.64,0
A539,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,PEG,Polymeric,Neutral,Organic,Lipid,Not Reported,Sphere,DLS,PBS,123,100~150,PBS,17.9,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A539,A65,1.95,0,5.21,0
A540,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,PEG,Polymeric,Neutral,Organic,Lipid,Not Reported,Sphere,DLS,PBS,114,100~150,PBS,18.1,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A540,A65,1.87,0,1.69,0
A541,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,131,100~150,PBS,26.1,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A541,A65,2.69,1.61,2.3,0
A542,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,135,100~150,PBS,30.1,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A542,A65,1.21,0,1.16,3.75
A543,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,144,100~150,PBS,30.2,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A543,A65,2.57,0,1.69,1.25
A544,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,254.6,>150,PBS,33.1,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A544,A65,1.45,0,1.48,1.34
A545,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,108,100~150,PBS,34.5,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A545,A65,1.13,0,1.34,0
A546,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,193.4,>150,PBS,42.1,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A546,A65,0,1.27,4.29,0
A547,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,125,100~150,PBS,46.2,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A547,A65,1.02,0,1.5,1.19
A548,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,128,100~150,PBS,47.4,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A548,A65,1.01,0,2.39,0
A549,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,157,>150,PBS,58.2,>+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A549,A65,1.19,0,2.3,1.61
A550,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,PEG,Polymeric,Neutral,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,115,100~150,Human Plasma,-13.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A550,A65,1.36,0,4.64,0
A551,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,PEG,Polymeric,Neutral,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,137,100~150,Human Plasma,-13.9,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A551,A65,1.87,0,1.69,0
A552,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOPG-DOPA,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,126,100~150,PBS,-14.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A552,A65,0,0,1.41,3.34
A553,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,329,>150,Human Plasma,-15.4,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A553,A65,1.45,0,1.48,1.34
A554,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,216,>150,Human Plasma,-17.9,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A554,A65,1.13,0,1.34,0
A555,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOPG-DOPA,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,152,>150,Human Plasma,-18.2,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A555,A65,1.09,0,1.39,1.68
A556,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,259,>150,Human Plasma,-19.3,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A556,A65,1.21,0,1.16,3.75
A557,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,236,>150,Human Plasma,-19.3,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A557,A65,0,1.27,4.29,0
A558,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,207,>150,Human Plasma,-20.4,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A558,A65,1.02,0,1.5,1.19
A559,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOPC-DOPE-PEG-DSPC-DPPC,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,301,>150,Human Plasma,-22.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A559,A65,1.42,0,3.46,0
A560,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,150,>150,Human Plasma,-23,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A560,A65,1.01,0,2.39,0
A561,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,PEG,Polymeric,Neutral,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,169,>150,Human Plasma,-24.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A561,A65,1.95,0,5.21,0
A562,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,182,>150,Human Plasma,-25.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A562,A65,2.69,1.61,2.3,0
A563,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOPG-DOPA,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,136,100~150,PBS,-26.6,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A563,A65,1.09,0,1.39,1.68
A564,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,211,>150,Human Plasma,-28.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A564,A65,1.19,0,2.3,1.61
A565,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOPG-DOPA,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,171,>150,Human Plasma,-28.6,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A565,A65,0,0,1.41,3.34
A566,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOTAP-DC-Chol,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,Human Plasma,178,>150,Human Plasma,-29.3,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,3,A566,A65,2.57,0,1.69,1.25
A567,A65,https://doi.org/10.1039/C6NR03898K,Nanoparticles-cell association predicted by protein corona fingerprints,2016,DOPC-DOPE-PEG-DSPC-DPPC,No Modification,No Modification,No Modification,Organic,Lipid,Not Reported,Sphere,DLS,PBS,191,>150,PBS,-8.4,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,10000,10,>10,60,30~60,N,37,Centrifugation,Not Reported,Not Reported,Not Reported,1,in vitro,Human,%-RPA,2,A567,A65,1.42,0,3.46,0
A568,A66,https://doi.org/10.1016/j.chroma.2014.01.077,The on-bead digestion of protein corona on nanoparticles by trypsin immobilized on the magnetic nanoparticle,2014,Iron Oxide,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,Not Reported,Not Reported,250,>150,Not Reported,-19.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,Not Reported,Not Reported,200,0.2,0~5,60,30~60,Y,37,Magnetic Pulldown,N/A,Not Reported,N/A,3,in vitro,Human,%-RPA,4,A568,A66,8.018930489,5.357730699,5.716921436,4.029008391
A581,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Mercaptosuccinic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,52,50~100,PBS,-14.23833333,-50~-10,Negative,0.287666667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A581,A69,10.7055,0.1767,1.0159,0.2895
A582,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,97.68,50~100,PBS,-12.15,-50~-10,Negative,0.095888889,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,3,A582,A69,27.3146,0,1.1718,0.138
A583,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Octadecylamine,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,41.78,<50,PBS,-11.75166667,-50~-10,Negative,0.42125,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A583,A69,4.3275,0.506,0.7739,6.2236
A584,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,60.9,50~100,PBS,-11.645,-50~-10,Negative,0.143777778,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,3,A584,A69,14.3749,0,0.9232,0.3242
A585,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Peptide sequence 'CVVIT',Peptide,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,103.94,100~150,PBS,-11.57666667,-50~-10,Negative,0.0575,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,3,A585,A69,9.8095,0,1.4563,0.1526
A586,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,11-Amino-1-undecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,108.27,100~150,PBS,-11.46666667,-50~-10,Negative,0.086111111,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A586,A69,2.5,0.1394,0.6825,0.8398
A587,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Peptide sequence 'CALNN',Peptide,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,65.4,50~100,PBS,-11.405,-50~-10,Negative,0.08625,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A587,A69,1.3667,0.0101,1.6849,0.1488
A588,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,N-Acetyl-L-cysteine,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,64.29,50~100,PBS,-11.355,-50~-10,Negative,0.248,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A588,A69,14.1892,0.2586,2.1641,0.9741
A589,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Mercaptoacetic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,61.91,50~100,PBS,-11.13833333,-50~-10,Negative,0.214444444,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A589,A69,5.0862,0.0223,1.9815,0.2192
A590,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,3-Mercaptopropionic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,55.65,50~100,PBS,-10.96166667,-50~-10,Negative,0.289111111,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A590,A69,14.5765,0.0924,0.8609,0.4543
A591,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Lipoic Acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,62.97,50~100,PBS,-10.8975,-50~-10,Negative,0.158,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A591,A69,9.7241,0.0156,1.1639,0.3071
A592,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Hexadecylamine,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,94.45,50~100,PBS,-10.795,-50~-10,Negative,0.106333333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A592,A69,5.2726,0.6053,1.1289,3.3051
A593,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,3-Mercaptopropionic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,60.99,50~100,PBS,-10.705,-50~-10,Negative,0.238444444,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A593,A69,7.9677,0.0373,2.2416,0.2198
A594,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,"5,5′-Dithiobis(2-nitrobenzoic acid) ",Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,105.18,100~150,PBS,-10.66,-50~-10,Negative,0.056777778,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A594,A69,2.1493,0.0377,1.4042,0.1852
A595,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,61.31,50~100,PBS,-10.59833333,-50~-10,Negative,0.201333333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A595,A69,11.5758,0.0149,0.9486,0.2938
A596,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,41.93,<50,PBS,-10.42333333,-50~-10,Negative,0.140388889,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A596,A69,16.8434,0.0833,1.8602,0.8934
A597,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,"5,5′-Dithiobis(2-nitrobenzoic acid) ",Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,60.27,50~100,PBS,-10.41666667,-50~-10,Negative,0.247555556,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A597,A69,4.8847,0.0142,1.0296,0.2794
A598,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,94.89,50~100,PBS,-10.26333333,-50~-10,Negative,0.103777778,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A598,A69,7.3696,0.0323,0.8768,0.4235
A599,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Mercaptoethanesulfonate ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,61.86,50~100,PBS,-10.21333333,-50~-10,Negative,0.286,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A599,A69,2.7102,0.1755,1.3923,0.2875
A600,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,N-(2-Mercaptopropionyl)glycine,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,57.28,50~100,PBS,-10.09,-50~-10,Negative,0.27,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A600,A69,10.1971,0.4205,0.9336,0.3801
A601,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,11-Amino-1-undecanethiol,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,77.26,50~100,PBS,-10.03333333,-50~-10,Negative,0.167,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A601,A69,3.1132,0.1533,0.4488,1.0505
A602,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Thiolated poly(allylamine),Polymeric,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,68.42,50~100,PBS,-9.8175,-10~+10,Neutral,0.278,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A602,A69,2.7605,0.0262,1.5743,1.0289
A603,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Hexadecyltrimethylammonium bromide,Surfactant,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,107.61,100~150,PBS,-9.765,-10~+10,Neutral,0.094833333,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A603,A69,2.6939,0.1163,2.34,1.0002
A604,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Peptide sequence 'CFGAILS',Peptide,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,68.38,50~100,PBS,-9.72,-10~+10,Neutral,0.0975,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A604,A69,4.793,0.1566,3.5842,0.8149
A605,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,47.03,<50,PBS,-9.7,-10~+10,Neutral,0.336444444,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A605,A69,1.9297,2.7075,2.5448,2.079
A606,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,114.53,100~150,PBS,-9.696666667,-10~+10,Neutral,0.138111111,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A606,A69,1.3692,0.3554,1.6433,0.5665
A607,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Bis(p-sulfonatophenyl)phenylphosphine,Other,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,105.01,100~150,PBS,-9.683333333,-10~+10,Neutral,0.073333333,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A607,A69,5.2882,0.069,2.0712,0.1696
A608,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,100.73,100~150,PBS,-9.628333333,-10~+10,Neutral,0.1,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,3,A608,A69,9.7731,0,1.5662,0.2762
A609,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,88.32,50~100,PBS,-9.618166667,-10~+10,Neutral,0.050333333,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A609,A69,2.314,0.0769,2.6169,1.0077
A610,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,53.24,50~100,PBS,-9.611666667,-10~+10,Neutral,0.260666667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A610,A69,3.5256,1.7891,2.0702,2.8362
A611,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,3-Mercaptopropionic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,100.75,100~150,PBS,-9.600833333,-10~+10,Neutral,0.087111111,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A611,A69,9.2743,0.0728,0.6529,0.2236
A612,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,11-Mercaptoundecanoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,66.32,50~100,PBS,-9.411666667,-10~+10,Neutral,0.161222222,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A612,A69,1.0932,0.218,0.8354,0.2777
A613,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Octadecylamine,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,95.18,50~100,PBS,-9.311666667,-10~+10,Neutral,0.099916667,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A613,A69,4.0542,0.3398,1.0294,3.2674
A614,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Hexadecyltrimethylammonium bromide,Surfactant,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,59.7,50~100,PBS,-9.25875,-10~+10,Neutral,0.371,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A614,A69,2.0837,0.4386,2.4019,0.9796
A615,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,N-Acetyl-L-cysteine,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,57.53,50~100,PBS,-9.111666667,-10~+10,Neutral,0.270222222,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A615,A69,13.135,0.8561,2.1816,1.3398
A616,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,39.99,<50,PBS,-8.9875,-10~+10,Neutral,0.146333333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A616,A69,2.6553,0.9547,2.8914,0.4577
A617,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,109.94,100~150,PBS,-8.966666667,-10~+10,Neutral,0.080888889,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A617,A69,1.9535,0.0117,2.9713,0.3849
A618,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Lipoic Acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,48.09,<50,PBS,-8.9525,-10~+10,Neutral,0.201166667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A618,A69,14.8636,0.0389,2.0614,0.5354
A619,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,6-Mercaptohexanoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,58.99,50~100,PBS,-8.918333333,-10~+10,Neutral,0.244333333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A619,A69,7.9894,0.0427,0.7733,0.2801
A620,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,16-Mercaptohexadecanoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,67.37,50~100,PBS,-8.81,-10~+10,Neutral,0.120777778,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A620,A69,1.5696,0.0693,0.8328,0.2806
A621,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,6-Amino-1-hexanethiol,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,90.06,50~100,PBS,-8.788333333,-10~+10,Neutral,0.215222222,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A621,A69,0.288,0.2263,0.6356,0.556
A622,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,4-Mercaptobenzoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,67.7,50~100,PBS,-8.738333333,-10~+10,Neutral,0.272888889,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A622,A69,10.8001,0.1036,0.6433,0.2546
A623,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,57.25,50~100,PBS,-8.731666667,-10~+10,Neutral,0.265888889,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A623,A69,12.9118,0.3807,1.8837,0.6451
A624,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,65.58,50~100,PBS,-8.713333333,-10~+10,Neutral,0.046444444,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A624,A69,2.3503,0.2473,4.3223,0.6482
A625,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,4-Mercaptobenzoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,102.9,100~150,PBS,-8.661666667,-10~+10,Neutral,0.082833333,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A625,A69,4.2305,0.0791,0.6688,0.1945
A626,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,16-Mercaptohexadecanoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,43.62,<50,PBS,-8.646666667,-10~+10,Neutral,0.154555556,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A626,A69,6.1779,0.021,0.6944,0.2748
A627,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,41.94,<50,PBS,-8.595,-10~+10,Neutral,0.131888889,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A627,A69,19.5566,0.0714,1.5763,0.5013
A628,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,54.03,50~100,PBS,-8.501666667,-10~+10,Neutral,0.217148148,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A628,A69,1.6288,0.0727,3.3394,0.7147
A629,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Tween-20,Polymeric,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,51.52,50~100,PBS,-8.451666667,-10~+10,Neutral,0.209083333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A629,A69,3.3381,0.4415,1.8962,5.1316
A630,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,"(11-Mercaptoundecyl)-N,N,N-trimethylammonium",Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,106.63,100~150,PBS,-8.354444444,-10~+10,Neutral,0.196666667,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A630,A69,0.3324,0.1516,0.8527,0.6877
A631,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,11-Mercaptoundecanoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,45.52,<50,PBS,-8.349722222,-10~+10,Neutral,0.165518519,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A631,A69,8.8801,0.0225,0.787,0.2213
A632,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,37.75,<50,PBS,-8.291666667,-10~+10,Neutral,0.206666667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A632,A69,13.1872,0.2367,2.1174,0.4934
A633,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,N-(2-Mercaptopropionyl)glycine,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,50.05,50~100,PBS,-8.138333333,-10~+10,Neutral,0.282444444,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A633,A69,8.0954,0.329,0.8322,0.1925
A634,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Polyvinyl Alcohol,Polymeric,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,106.12,100~150,PBS,-8.073333333,-10~+10,Neutral,0.070166667,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A634,A69,2.4777,0.0174,1.1512,2.6994
A635,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,"(11-Mercaptoundecyl)-N,N,N-trimethylammonium",Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,127.34,100~150,PBS,-8.065833333,-10~+10,Neutral,0.173240741,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A635,A69,0.7084,0.2485,1.2616,1.1722
A636,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Bis(p-sulfonatophenyl)phenylphosphine,Other,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,48.66,<50,PBS,-8.028333333,-10~+10,Neutral,0.115222222,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A636,A69,6.3023,0.0074,1.5047,0.7243
A637,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,43.77,<50,PBS,-7.945833333,-10~+10,Neutral,0.3395,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A637,A69,5.459,1.9798,1.827,7.7835
A638,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,11-Amino-1-undecanethiol,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,55.98,50~100,PBS,-7.945,-10~+10,Neutral,0.272555556,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A638,A69,1.776,0.2406,0.6876,0.8023
A639,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,"(11-Mercaptoundecyl)-N,N,N-trimethylammonium",Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,122.28,100~150,PBS,-7.943333333,-10~+10,Neutral,0.203333333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A639,A69,0.3132,0.3461,0.955,0.8639
A640,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,58.53,50~100,PBS,-7.907666667,-10~+10,Neutral,0.267333333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A640,A69,2.6079,0.0388,3.1362,1.0353
A641,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,41.64,<50,PBS,-7.806666667,-10~+10,Neutral,0.129333333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A641,A69,17.0126,0.2176,1.9179,0.9661
A642,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Hexadecylamine,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,54.89,50~100,PBS,-7.726666667,-10~+10,Neutral,0.234777778,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A642,A69,3.4087,1.2292,1.2271,7.8758
A643,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,61.79,50~100,PBS,-7.573333333,-10~+10,Neutral,0.183888889,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A643,A69,15.9412,0.7329,1.4645,1.7388
A644,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,44.6,<50,PBS,-7.48,-10~+10,Neutral,0.092888889,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,3,A644,A69,2.5819,0,1.7301,1.4379
A645,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,43.48,<50,PBS,-7.368333333,-10~+10,Neutral,0.145333333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A645,A69,14.048,0.1103,1.9077,0.5783
A646,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,52.42,50~100,PBS,-7.198333333,-10~+10,Neutral,0.215333333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A646,A69,15.0996,0.1202,1.8036,0.7384
A647,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,71.85,50~100,PBS,-7.196666667,-10~+10,Neutral,0.155555556,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A647,A69,0.6293,0.4194,1.0965,0.5063
A648,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Thiolated poly(ethyleneimine),Polymeric,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,52.46,50~100,PBS,-7.043333333,-10~+10,Neutral,0.176333333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,3,A648,A69,0,0.1402,0.5454,0.6005
A649,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,42.05,<50,PBS,-6.778333333,-10~+10,Neutral,0.193222222,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A649,A69,15.3632,0.2899,2.0306,0.8036
A650,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,44.43,<50,PBS,-6.728333333,-10~+10,Neutral,0.183888889,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A650,A69,14.8049,0.1628,2.1602,0.838
A651,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Pluronic F-127,Other,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,46.63,<50,PBS,-6.633333333,-10~+10,Neutral,0.1965,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A651,A69,2.3711,0.0475,2.0983,2.0631
A652,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,29.68,<50,PBS,-6.628333333,-10~+10,Neutral,0.151777778,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,3,A652,A69,7.9376,0.174,2.593,0
A653,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Peptide sequence 'CALNN',Peptide,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.8,<50,PBS,-6.536666667,-10~+10,Neutral,0.154083333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,3,A653,A69,1.516,0,1.2106,0.784
A654,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,48.4,<50,PBS,-6.523333333,-10~+10,Neutral,0.308,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A654,A69,1.9952,1.5842,2.2823,3.877
A655,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,93.52,50~100,PBS,-6.52,-10~+10,Neutral,0.0545,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A655,A69,19.3243,0.0102,1.214,0.5028
A656,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Thiolated poly(ethyleneimine),Polymeric,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,68.07,50~100,PBS,-6.483333333,-10~+10,Neutral,0.310111111,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A656,A69,1.5762,0.0184,1.3832,1.0506
A657,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,47.34,<50,PBS,-6.373333333,-10~+10,Neutral,0.237111111,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A657,A69,0.6616,0.5636,1.2259,1.1079
A658,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,59.93,50~100,PBS,-6.096666667,-10~+10,Neutral,0.366916667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A658,A69,5.7743,2.1345,3.0525,7.6567
A659,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Stearic acid,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,46.53,<50,PBS,-6.091666667,-10~+10,Neutral,0.214166667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A659,A69,1.8817,0.1563,2.502,1.1268
A660,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Polyvinyl Alcohol,Polymeric,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,53.12,50~100,PBS,-6.063333333,-10~+10,Neutral,0.178083333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A660,A69,1.1729,0.0103,1.4191,1.8703
A661,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,52.02,50~100,PBS,-5.993333333,-10~+10,Neutral,0.193666667,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A661,A69,4.166,0.0044,1.4926,0.4287
A662,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.69,<50,PBS,-5.913333333,-10~+10,Neutral,0.153555556,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A662,A69,1.4426,0.0354,2.0386,1.3428
A663,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,100.13,100~150,PBS,-5.705,-10~+10,Neutral,0.370166667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A663,A69,3.1902,1.4478,2.7791,3.2996
A664,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,55.39,50~100,PBS,-5.676666667,-10~+10,Neutral,0.236222222,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A664,A69,15.9214,0.2176,1.5611,0.5703
A665,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,72.3,50~100,PBS,-5.643333333,-10~+10,Neutral,0.201277778,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A665,A69,0.2199,0.0077,0.5816,0.9601
A666,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,61.43,50~100,PBS,-5.518333333,-10~+10,Neutral,0.225666667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A666,A69,5.9686,1.0349,1.7166,1.2934
A667,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,58.95,50~100,PBS,-5.455,-10~+10,Neutral,0.345916667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A667,A69,0.9816,2.0658,0.9501,5.4144
A668,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,53.41,50~100,PBS,-5.43,-10~+10,Neutral,0.085666667,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A668,A69,4.7848,1.3818,1.831,1.4578
A669,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,44.75,<50,PBS,-5.351666667,-10~+10,Neutral,0.298666667,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A669,A69,13.4462,0.5279,1.5522,1.5311
A670,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,41.88,<50,PBS,-5.258333333,-10~+10,Neutral,0.118444444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A670,A69,15.5634,0.312,1.7607,0.8362
A671,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,Poly(vinylpyrrolidone),Polymeric,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,52.96,50~100,PBS,-5.238333333,-10~+10,Neutral,0.216875,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A671,A69,0.7547,0.1263,3.7425,1.5212
A672,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,55.07,50~100,PBS,-5.140833333,-10~+10,Neutral,0.251833333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A672,A69,6.6672,1.6371,2.0328,2.5859
A673,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,51.18,50~100,PBS,-5.0435,-10~+10,Neutral,0.162888889,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A673,A69,1.3583,0.0752,2.6572,1.75
A674,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,(11-Mercaptoundecyl)tetra(ethylene glycol),Alkylthiols,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,226.51,>150,PBS,-5.007083333,-10~+10,Neutral,0.438527778,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A674,A69,1.8716,0.8666,25.4707,0.9679
A675,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,84.87,50~100,PBS,-4.4106,-10~+10,Neutral,0.037888889,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A675,A69,2.9946,0.3232,2.6755,0.3971
A676,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,47,<50,PBS,-3.916833333,-10~+10,Neutral,0.178333333,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,4500,4,45,1,in vitro,Human,%-RPA,4,A676,A69,17.9674,0.4496,1.3071,1.4993
A677,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,64.65,50~100,PBS,-3.891333333,-10~+10,Neutral,0.252333333,>0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A677,A69,0.8547,0.3478,1.853,0.4715
A678,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,47.07,<50,PBS,-3.772566667,-10~+10,Neutral,0.124555556,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,3,A678,A69,2.4535,0.3443,1.4249,0
A679,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,2-Napthalenethiol ,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,100.88,100~150,PBS,-3.580333333,-10~+10,Neutral,0.083916667,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A679,A69,0.6644,0.1398,1.1576,0.1527
A680,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,48.76,<50,PBS,-2.935,-10~+10,Neutral,0.133888889,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A680,A69,1.6459,0.7033,2.6648,0.619
A681,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,33.05,<50,PBS,-2.753333333,-10~+10,Neutral,0.158222222,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,4,A681,A69,2.0693,0.9045,3.1431,0.8781
A682,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,110.75,100~150,PBS,-2.232166667,-10~+10,Neutral,0.077777778,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A682,A69,1.3054,0.1439,3.5379,0.5143
A683,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,98.21,50~100,PBS,-2.015,-10~+10,Neutral,0.044222222,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A683,A69,3.237,0.4116,3.0549,0.558
A684,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,34.77,<50,PBS,-1.730833333,-10~+10,Neutral,0.134666667,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,15000,4,45,1,in vitro,Human,%-RPA,3,A684,A69,1.3124,0.3683,1.2703,0
A685,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Au,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,127.22,100~150,PBS,-0.61,-10~+10,Neutral,0.027666667,0~0.1,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,1500,4,45,1,in vitro,Human,%-RPA,4,A685,A69,1.6401,0.7767,5.8736,0.5654
A686,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,11-Amino-1-undecanethiol,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A686,A69,0.5035,0.0459,1.0526,0.4166
A687,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,Citrate,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,3,A687,A69,1.7255,0,1.4331,0.1919
A688,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A688,A69,1.0486,0.2044,3.4736,0.3214
A689,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,1-Dodecanethiol,Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A689,A69,0.6787,0.0833,1.2811,0.8775
A690,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,Hexadecylamine,Amines,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A690,A69,2.7067,0.1308,1.0363,0.7465
A691,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,Lipoic Acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,3,A691,A69,3.7009,0,1.4185,0.4083
A692,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,Mercaptoacetic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A692,A69,12.397,0.06,1.0942,0.2948
A693,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,4-Mercaptobenzoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A693,A69,2.1915,0.0329,0.8788,0.2878
A694,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,2-Mercaptoethanesulfonate,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A694,A69,3.4784,0.1616,0.822,0.2492
A695,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,16-Mercaptohexadecanoic acid,Alkylthiols,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,2,A695,A69,4.7949,0,0.5746,0
A696,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A696,A69,0.6454,0.1268,3.3734,0.534
A697,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,"(11-Mercaptoundecyl)-N,N,N-trimethylammonium",Alkylthiols,Positive,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A697,A69,0.596,0.0956,1.1703,0.7633
A698,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,PEG,Polymeric,Neutral,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A698,A69,0.9854,0.2143,2.3844,0.5436
A699,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,Amino Acid,Amino Acid,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,3,A699,A69,0.0597,0,0.6242,0.3706
A700,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,Polyvinyl Alcohol,Polymeric,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,3,A700,A69,4.6277,0,0.906,1.7405
A701,A69,https://doi.org/10.1021/nn406018q,Protein corona fingerprinting predicts the cellular interaction of gold and silver nanoparticles,2014,Ag,Stearic acid,Carboxylic Acids,Negative,Inorganic,Metal,N/A,Sphere,DLS,PBS,38.4,<50,PBS,-13.5,-50~-10,Negative,0.126944444,0.1~0.2,Human Plasma,None,N/A,100,50~100,40,cm^2,1000,Not Reported,Not Reported,480,>60,N,25,Centrifugation,5000,4,45,1,in vitro,Human,%-RPA,4,A701,A69,7.8821,0.0703,1.5258,3.3301
A706,A71,https://doi.org/10.1039/C5NR08196C,Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake,2016,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,KCl,116,100~150,KCl,42.8,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20000,Not Reported,60,3,in vitro,Human,%-RPA,3,A706,A71,0.36,0,0.9,18.71
A707,A71,https://doi.org/10.1039/C5NR08196C,Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake,2016,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,KCl,116,100~150,KCl,42.8,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20001,Not Reported,60,3,in vitro,Human,%-RPA,3,A707,A71,0,0.2,0.5,0.14
A708,A71,https://doi.org/10.1039/C5NR08196C,Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake,2016,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,KCl,116,100~150,KCl,42.8,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20002,Not Reported,60,3,in vitro,Human,%-RPA,3,A708,A71,0.12,0,0.63,7.28
A709,A71,https://doi.org/10.1039/C5NR08196C,Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake,2016,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,KCl,116,100~150,KCl,42.8,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20003,Not Reported,60,3,in vitro,Human,%-RPA,3,A709,A71,0,0.16,0.5,0.17
A710,A71,https://doi.org/10.1039/C5NR08196C,Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake,2016,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,KCl,116,100~150,KCl,42.8,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20004,Not Reported,60,3,in vitro,Human,%-RPA,3,A710,A71,0.03,0,0.05,5.44
A711,A71,https://doi.org/10.1039/C5NR08196C,Protein source and choice of anticoagulant decisively affect nanoparticle protein corona and cellular uptake,2016,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,KCl,116,100~150,KCl,42.8,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.05,m^2,300,Not Reported,Not Reported,60,30~60,Y,37,Centrifugation,20005,Not Reported,60,3,in vitro,Human,%-RPA,3,A711,A71,0,0.12,0.55,0.11
A712,A72,https://doi.org/10.1371/journal.pone.0129008,Proteomics analysis reveals distinct corona composition on magnetic nanoparticles with different surface coatings: Implications for interactions with primary human macrophages,2015,Iron Oxide,Silica,Silicon-Based,Neutral,Inorganic,Metal Oxide,N/A,Sphere,DLS,RPMI,391.7,>150,RPMI,-11.24,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,300,Not Reported,Not Reported,Not Reported,>60,Not Reported,Not Reported,Centrifugation,3500,4,15,3,in vitro,Human,%-RPA,4,A712,A72,3.308586708,0.292143957,2.095044203,0.42197544
A713,A72,https://doi.org/10.1371/journal.pone.0129008,Proteomics analysis reveals distinct corona composition on magnetic nanoparticles with different surface coatings: Implications for interactions with primary human macrophages,2015,Iron Oxide,Silica,Silicon-Based,Neutral,Inorganic,Metal Oxide,N/A,Sphere,DLS,RPMI,124.8,100~150,RPMI,-19.92,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,1,mg/mL,300,Not Reported,Not Reported,Not Reported,>60,Not Reported,Not Reported,Centrifugation,3500,4,15,3,in vitro,Human,%-RPA,4,A713,A72,3.308586708,0.292143957,2.095044203,0.42197544
A714,A73,https://doi.org/10.1039/C4MB00292J,A proteomics-based methodology to investigate the protein corona effect for targeted drug delivery,2014,DOTAP/DOPC/DC-Chol/DOPE/DOPE-PEG2k,PEG,Polymeric,Neutral,Organic,Lipid,1:1:1:0.7:0.3,Sphere,Not Reported,Not Reported,60,50~100,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1440,>60,N,37,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,4,A714,A73,1.95,0.81,5.21,0.84
A715,A74,https://doi.org/10.1021/am404171h,"Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles",2013,DOTAP/DNA,No Modification,No Modification,No Modification,Organic,Lipid-DNA,N/A,Sphere,DLS,Not Reported,223.5,>150,Not Reported,49.5,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1440,>60,N,37,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,3,A715,A74,0,2.9,7.5,3.1
A716,A74,https://doi.org/10.1021/am404171h,"Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles",2013,DOTAP/DNA,No Modification,No Modification,No Modification,Organic,Lipid-DNA,N/A,Sphere,DLS,Not Reported,223.5,>150,Not Reported,49.5,+10~+50,Positive,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1440,>60,N,37,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,3,A716,A74,0,3,7.8,3.3
A717,A74,https://doi.org/10.1021/am404171h,"Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles",2013,DOTAP/DNA,No Modification,No Modification,No Modification,Organic,Lipid-DNA,N/A,Sphere,DLS,Not Reported,287.7,>150,Not Reported,-7.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1440,>60,N,37,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,3,A717,A74,0,2.9,7.5,3.1
A718,A74,https://doi.org/10.1021/am404171h,"Selective targeting capability acquired with a protein corona adsorbed on the surface of 1,2-dioleoyl-3-trimethylammonium propane/dna nanoparticles",2013,DOTAP/DNA,No Modification,No Modification,No Modification,Organic,Lipid-DNA,N/A,Sphere,DLS,Not Reported,287.7,>150,Not Reported,-7.6,-10~+10,Neutral,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,50,%-v-v,Not Reported,Not Reported,Not Reported,1440,>60,N,37,Not Reported,Not Reported,Not Reported,Not Reported,Not Reported,in vitro,Human,%-RPA,3,A718,A74,0,3,7.8,3.3
A744,A78,https://doi.org/10.1371/journal.pone.0182906,The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells,2017,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,220.8,>150,HEPES,-19.9,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,10,<50,1,mg/mL,Not Reported,Not Reported,Not Reported,1440,>60,N,37,Magnetic Pulldown,N/A,N/A,N/A,3,in vitro,Human,%-RPA,4,A744,A78,1.11,0.08,2.59,0.73
A747,A78,https://doi.org/10.1371/journal.pone.0182906,The species origin of the serum in the culture medium influences the in vitro toxicity of silica nanoparticles to HepG2 cells,2017,Silica,No Modification,No Modification,No Modification,Inorganic,Silica,N/A,Sphere,DLS,PBS,143.5,100~150,HEPES,-39.1,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,10,<50,1,mg/mL,Not Reported,Not Reported,Not Reported,1440,>60,N,37,Magnetic Pulldown,N/A,N/A,N/A,3,in vitro,Human,%-RPA,4,A747,A78,1.11,0.08,2.59,0.73
A778,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A778,A82,0.32,2.03,1.03,2.11
A779,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A779,A82,0.52,1.03,0.25,14.89
A780,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A780,A82,0.56,1.01,0.22,14.99
A781,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A781,A82,0.65,1.23,0.14,16.77
A782,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,70,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A782,A82,0.16,1.01,0.65,0.35
A783,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,70,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A783,A82,2.94,0.14,0.29,2.09
A784,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,74,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A784,A82,0.07,1,0.55,1.34
A785,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,74,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A785,A82,0.56,0.11,0.28,13.76
A786,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A786,A82,0.32,2.03,1.03,2.11
A787,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A787,A82,0.52,1.03,0.25,14.89
A788,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A788,A82,0.56,1.01,0.22,14.99
A789,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,No Modification,No Modification,No Modification,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,73,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A789,A82,0.65,1.23,0.14,16.77
A790,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,70,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A790,A82,0.16,1.01,0.65,0.35
A791,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,COOH,Carboxylic Acids,Negative,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,70,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A791,A82,2.94,0.14,0.29,2.09
A792,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,74,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A792,A82,0.07,1,0.55,1.34
A793,A82,https://doi.org/10.1039/C7NR02977B,Visualization of the protein corona: Towards a biomolecular understanding of nanoparticle-cell-interactions,2017,Polystyrene,NH2,Amines,Positive,Organic,Polystyrene,N/A,Sphere,DLS,DI-H2O,74,50~100,DI-H2O,-13.5,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,0.152,m^2/mL,1000,Not Reported,Not Reported,60,30~60,N,37,Centrifugation,20000,4,60,3,in vitro,Human,%-RPA,4,A793,A82,0.56,0.11,0.28,13.76
A794,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A794,A83,0,2.18,2.84,0.28
A795,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,4,A795,A83,0.86,2.3,3.33,0.3
A796,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A796,A83,0,2.18,2.84,0.28
A797,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,4,A797,A83,1.25,1.07,3.09,0.34
A798,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A798,A83,0,1.03,4.39,0.27
A799,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,4,A799,A83,0.43,0.96,4.61,0.88
A800,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A800,A83,0,1.57,1.86,0
A801,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A801,A83,0,1.63,3.38,0
A802,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A802,A83,0,1.94,3.1,1
A803,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A803,A83,3.2,2.02,3.4,0
A804,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A804,A83,0,1.16,2.88,0
A805,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,EMT-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-44,-50~-10,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,4,%-w-w,Not Reported,4,0~5,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A805,A83,0,0.81,2.74,0
A806,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,4,A806,A83,0.97,1.14,3.01,0.22
A807,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A807,A83,0,1.75,4.18,0
A808,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A808,A83,0,1.43,4.56,0
A809,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A809,A83,4.83,2.71,6.53,0
A810,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A810,A83,1.55,1.09,3.36,0
A811,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,Not Reported,10,<50,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,4,A811,A83,0.63,1.45,5.21,0.43
A812,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A812,A83,5.75,1.36,5.25,0
A813,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A813,A83,0,2.01,5.76,0
A814,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A814,A83,0.63,0.27,3.31,0
A815,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A815,A83,0,0.17,3.09,0
A816,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,3,A816,A83,2.27,0.48,2.19,0
A817,A83,https://doi.org/10.1038/srep17259,Zeolite Nanoparticles for Selective Sorption of Plasma Proteins,2015,FAU-Zeolite,No Modification,No Modification,No Modification,Inorganic,Metal Oxide,N/A,Sphere,DLS,KCl,10,<50,KCl,-50,<-50,Negative,Not Reported,Not Reported,Human Plasma,None,N/A,100,50~100,12,%-w-w,Not Reported,12,>10,60,30~60,N,37,Centrifugation,24000,Not Reported,30,3,in vitro,Human,%-RPA,2,A817,A83,0,0.99,2.73,0
